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The enzyme adenosine monophosphate activated protein kinase (AMPK), a 
critical regulator of energy metabolism in the body, is activated by a rise in the 
cellular AMP: ATP ratio in response to metabolic stresses such as hypoxia. The 
work in this thesis arises from the recent characterization by Mahmoud, A. (PhD 
thesis, University of Edinburgh, 2015) of the response to hypoxia of mice lacking 
the α1 and α2 isoforms of the catalytic subunit of the AMPK molecule. Targeted 
conditional deletion of the genes encoding the α1 and/or α2 subunits of AMPK in 
catecholaminergic cells (including cells in the carotid body and the brain) was 
achieved by crossing mice expressing Cre-recombinase under the control of the 
tyrosine hydroxylase (TH) promoter, with mice in which either or both α subunits 
of AMPK were flanked by loxP sequences. AMPKα1/α2-/- mice showed a 
profoundly abnormal ventilatory response to hypoxia, compared to 
AMPKα1/α2fl/fl controls. Interestingly however, in vitro recordings from the 
CSN in isolated carotid body preparations from AMPKα1/α2-/- mice showed that 
the carotid body afferent response to hypoxia was completely normal in these 
mice. The abnormal response to hypoxia in AMPKα1/α2-/- mice appears therefore 
to be due to a deficit in the central, catecholaminergic brainstem neurons involved 
in respiratory control, where a lack of AMPK activation appears to inhibit the 
normal hypoxia-induced hyperventilation. While the importance of the peripheral 
carotid body chemoreceptors in oxygen-sensing has long been established, these 
findings indicate that the synergistic activation of AMPK in central brainstem 
neurons by the hypoxic metabolic stress, is also required for the normal response 
to hypoxia.  
In this thesis, the responses to hypoxia of AMPKα1/α2-/- mice, AMPKα2-/- mice 
and AMPKα1/α2fl/fl controls were studied using whole-body plethysmography. 
The findings showed that AMPKα1/α2-/- mice displayed a respiratory phenotype 
of  longer and increased number of apnoeas coupled with hypoventilation in 
comparison to both the AMPKα2-/- mice and AMPKα1/α2fl/fl controls 
confirming the earlier results of Mahmoud (2015). In addition TH 
immunostaining in the carotid bodies of AMPKα1/α2-/- mice and 
AMPKα1/α2fl/fl controls was compared to determine if there was any change in 
the number or density of TH-positive cells in the AMPKα1/α2-/- animals, and the 
gross result showed a 2-fold decrease in the number of TH- immunopositive cells 
in the AMPKα1/α2-/- mice as compared to the AMPKα1/α2fl/fl. Intriguingly, if  
this observation is statistically confirm coupled with the unattenuation of the 
normal afferent discharge from the carotid bodies of AMPKα1/α2-/- mice then it 
is plausible that a certain degree of redundancy operates in the physiology of the 
carotid body with regards to oxygen sensing or  the glomus cells type lost may be 
those not involved in mediating the response to hypoxia. 
 In the main part of this work, c-fos and TH immunohistochemistry were used to 
investigate the activation of brainstem catecholaminergic neurons by hypoxia, in 
AMPKα1/α2-/- mice, AMPKα2-/- mice and AMPKα1/α2fl/fl controls. Significant 
differences in c-fos immunostaining of TH+ve neurons were observed in the SubP 
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region of the NTS, and the C2 region and the A1 region of the ventral respiratory 
group, implicating these specific regions in the abnormal hypoxic ventilatory 
response in AMPKα1/α2-/- animals. Catecholaminergic neurons in these 
brainstem regions are known to play key role in the control of breathing as a loss 
of these neurons or decrease in their catecholamine content results in severe 
respiratory abnormalities including respiratory arrhythmias and apnoeas as seen in 
the Rett syndrome. 
 A significant hyperplasia of the brainstem stem catecholaminergic neurons was 
also observed in both the AMPKα1/α2-/-and AMPKα2-/- mice consistent with the 
known inhibitory effects of AMPK activation on cell growth and proliferation. 
Finally a pilot study was carried out to determine if the respiratory phenotype 
observed in AMPKα1/α2-/- mice could be replicated using a viral vector to 
deliver Cre-recombinase to targeted areas in the brainstem in AMPKα1/α2fl/fl 
mice, to knock out AMPK in specific neuronal subgroups. Although the data 
obtained from this set of experiments were encouraging, the animals did not show 
the respiratory phenotype as observed in the conditional knockout mice maybe 
due to poor targeting of specific brainstem neuronal populations including the 
SubP region or inadequate transfection of these cells due to low viral titre. One 
advantage of this pilot work was that responses due to compensatory mechanisms 
as may be the case in the conditional knock out animals were eliminated.    
These findings are of interest in understanding the neural control of respiration in 
hypoxia and acclimatization to altitude, and may also suggest new avenues for 
therapeutic intervention in breathing disorders such as non-obstructive sleep 
apnoea. It also raises the possibility that AMPK may be a useful therapeutic tool 
for disease conditions whose etiology is based on cellular proliferation, such as 






Adenosine monophosphate activated protein kinase (AMPK) is an important 
cellular enzyme that is involved in the regulation of energy metabolism by 
regulating the supply of ATP in all tissues of the body. In this work the role of 
AMPK in the response of mice to low oxygen tension (hypoxia) was studied, 
using a mouse model in which the α–catalytic subunit of the AMPK molecule had 
been deleted.  In contrast to normal animals that showed marked hyperventilation 
upon exposure to hypoxia, in AMPK-deficient mice the hyperventilatory response 
was reduced and interspersed with apnoeas.  The areas of the brain that may be 
responsible for this abnormal ventilatory response in the AMPK-deficient mice 
were investigated using immunohistochemical staining for c-fos, a marker for 
neuronal activation, following exposure to hypoxia. The results identified several 
areas of the brainstem where this abnormal ventilatory response may arise, and 
showed that AMPK in these brainstem areas plays an important part in producing 
the normal hyperventilatory response to hypoxia. These findings throw more light 
on the understanding of the control of breathing during hypoxia, and may also be 
of value in the management or treatment of breathing disorders such as non-
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The moment-to-moment control of energy metabolism in the body is essential for the 
survival of all organisms.  In mammalian cells, the enzyme adenosine 
monophosphate activated protein kinase (AMPK) has been recognized as the critical 
regulator of this energy homeostasis (Viollet et al., 2010, Carling et al., 2011; Hardie 
et al., 2012; Miyamoto et al., 2015). AMPK  is activated by  a rise in the  cellular  
adenosine 5’- monophosphate (AMP) : adenosine 5’- triphosphate (ATP)  ratio in 
response  to  metabolic  stresses  such as hypoxia, ischemia, glucose deprivation, 
starvation, heat shock and muscle contraction (Kahn et al. 2005; Towler and Hardie, 
2007;  Fisslthaler and Fleming, 2009, Viollet  et al., 2010; Figure 1.1). On activation 
AMPK  switches on ATP  generating   processes such as  glycolysis in the heart , 
mitochondrial biogenesis  in the muscle and fatty acid uptake and oxidation  in 
multiple tissues, while  switching off  ATP–consuming biosynthetic  pathways such 
as fatty acid  and protein synthesis, cholesterol synthesis  in the liver, cell growth and  
proliferation (Towler and Hardie, 2007; Viollet  et al., 2010; Figure 1.1). 
 The work in this thesis is based on the recent characterization by Mahmoud,  A. 
(PhD  Thesis, University of Edinburgh; Mahmoud 2015a) of the response to hypoxia 
of mice lacking the α1 and α2 isoforms of the α-catalytic subunit of the AMPK 




brain), which are known to be involved in the control of  breathing (Urena et 
al.,1994;  Montoro, et al.,1996; Lopez-Barneo et al.,2008; Hirooka et al., 1997; 
Erickson and Millhornm 1994;  Teppema et al.,1997; Greenberg et al; 1999). 
Targeted conditional deletion of the genes  encoding  the α1 and α2 catalytic subunits 




 animals, herein referred to as double-knockout or DKO 
animals) was achieved by crossing mice expressing  Cre-recombinase under the 
control of  the tyrosine hydroxylase (TH) promoter (TH-Cre mice), with mice in 
which either or both  of the isoforms of the α subunit of the AMPK  were flanked by 




 , herein referred to as double-floxed or DFlox 
mice).  
Upon exposure to hypoxia (8% O2, 0.05% CO2, balanced with N2), Mahmood 
(2015a) demonstrated that AMPK knockout (DKO) mice showed marked abnormal 
ventilatory responses that were  characterized  by apnoeas  and hypoventilation, in 
contrast to the hyperventilation that was observed in DFlox controls.  It  is well 
established  that the carotid body is the  primary sensory organ that detects changes 
in the partial pressure  of oxygen in the arterial blood and that  during hypoxia it 
transmits  afferent signals through the carotid sinus nerve (CSN) to brainstem 
neurons  to elicit the hypoxic  hyperventilatory response (Prabhakar, 2000; Lui et al., 
2009; Lopez-Barneo et al.,2009). Strikingly however, in vitro recordings from the 
CSN in isolated carotid body preparations of DKO mice showed that the carotid 
body sensory response to hypoxia was normal (Mahmoud et al., 2015a). The 
observed abnormal response to hypoxia in DKO animals is therefore not due  to an 




deficit in the central brainstem respiratory control network, which fails to respond 
correctly to the hypoxia signaled by the CSN afferents. In this work, I therefore 
investigated the brainstem catecholaminergic neurons which are known to be 
involved in the control of respiration, to determine the effects of AMPK deletion on 
their response to hypoxia in DKO mice. 
The central regulation of ventilation occurs in the brainstem respiratory centres, 
which contains well-defined catecholaminergic neuronal populations such as the 
A1/A2 noradrenergic neurons and the C1/C2 adrenergic neurons that are involved in 
respiratory control (Li and Nattie, 2006; Buller et al., 2008; Li et al., 2008; Soliz et 
al., 2008; Smith, et al., 2013; Guyenet et al.2013; Zoccal et al., 2014). The abnormal 
response to hypoxia observed in DKO mice may therefore be due to a deficit in any 
or all of these central catecholaminergic brainstem neurons, where the deletion of 
AMPK may result in the loss of the normal hyperventilatory response to hypoxia. 
This possible importance of AMPK and its activation by hypoxia in central 
brainstem neuronal pathways is potentially of great interest, as it may be relevant in 
certain disorders of breathing such as some types of sleep apnoeas, and in the 
physiological adaptations to living at altitude. In the main part of this thesis, I 
therefore investigated the areas of the brainstem in which AMPK may mediate this 







1.2   Literature Review Part 1: AMPK  
AMPK belongs to the family of protein kinases that have been highly conserved in 
all eukaryotic cells (Stein et al., 2000; Hardie et al., 1998; Hardie et al., 2003; 
Motoshima et al., 2006; Towler and Hardie, 2007; Xiao et al., 2007; Emerling et al., 
2009; Hardie, 2004; Viollet et al., 2010; Xiao et al., 2011; Hardie, et al., 2012; 
Hardie, 2013). It is homologous to the saccharomyces cerevisiae protein kinase Snf1 
which is required for yeast survival during conditions of glucose starvation (Celenza 
and Carlson, 1986; Hardie et al., 1994; Woods et al., 1994; Steinberg and Kemp, 
2009; Viollet et al., 2010). 
AMPK is activated by a rise in the cellular AMP: ATP ratio resulting from metabolic 
stresses that deplete ATP either by interfering with its production (e.g hypoxia, 
ischemia, glucose deprivation, starvation and heat shock) or accelerating its 
consumption (e.g muscle contraction, vigorous exercise)(Kahn et al. 2005; 
Motoshima et al., 2006; Towler and Hardie, 2007;  Fisslthaler and Fleming, 2009, 
Viollet  et al., 2010).  Upon activation, AMPK turns off ATP-consuming processes 
such as  lipid and glycogen synthesis, cell growth and proliferation, while turning  on 
ATP-generating processes such as fatty acid oxidation and glycolysis  (Carling 2004; 
Towler and Hardie, 2007; Emerling et al., 2009). Thereby making energy available 
for use under conditions where ATP is limited (Emerling et al., 2009). 
1.2.1 Structure of mammalian AMPK  
AMPK is a heterotrimeric complex, consisting of an α-catalytic subunit and two 




Evans,2007;  Evans et al., 2009; Viollet et al., 2010; Carling et al., 2012; Ruderman 
et al., 2013; Miyamoto et al., 2015). In mammals isoforms of each subunit exist, α 
(α1 and α2), β (β1and β2), γ (γ1,γ2 and γ3) and they are products of different  genes 
(Fryer and Carling, 2005 ; Viollet et al., 2010; Carling et al., 2012; Ruderman et al., 
2013; Miyamoto et al., 2015). There are 2 or 3 genes that encode for each subunit, 
resulting in at least 12 possible heterotrimeric complexes (Fryer and Carling, 2005; 
Towler and Hardie, 2007; Viollet et al., 2010).  Also alternative splicing of some of 
the genes ( e.g  γ2 and γ3 isoforms) and the use of different promoters further 
increase the diversity and complexity of AMPK  system (Carling, 2004; Fryer and 
Carling, 2005; Towler and Hardie, 2007; Viollet et al., 2010). There are indications 
that the different isoforms give rise to both tissue specificity, and the specificity in 
response to a specific type of stimulus (metabolic stress) by AMPK (Fryer and 
Carling, 2005; Viollet et al., 2010).  For example the γ3 isoform expressed 
predominately in the fast-twitch type II fibres of the skeletal muscles, appears to play 
a role in the control of fuel utilization in these tissues (Barnes et al., 2004; Mahlapuu 
et al., 2004; Fryer and Carling, 2005). 
The AMPKα1 isoform is richly expressed in the adipose tissue, pancreas, lung, 
spleen and kidney and is predominantly in the cytoplasm (Towler and Hardie, 2007; 
Fisslthaler and Fleming, 2009; Viollet et al., 2010). In the other hand, the AMPKα1 
isoform in carotid body type  cells is associated with the plasma membrane, while in 
the airway epithelial cells it is also associated mainly with its apical membrane 
(Hallows et al., 2003; Evans et al., 2005; Towler and Hardie, 2007). The AMPKα2- 




neurons, skeletal and cardiac muscles (Salt et al., 1998; Turnley et al., 1999; Towler 
and Hardie, 2007; Fisslthaler and Fleming, 2009; Viollet et al., 2010).  
The are several amino acid residues in the α subunit  that can be phosphorylated both 
in vitro and in vivo and one of such is Threonine 172, whose phosphorylation is 
required for AMPK activation (Carling, 2004) (see Figure 1.2). The α1 and /or α2 
subunit is the catalytic domain of the AMPK molecule and thus it full functionality 
depends on the intact presence of this domain.  Studies in high- altitude dwellers (e.g 
Andean populations) have shown that the gene for the AMPK-α1 subunit (PRAKK1) 
has been modified by natural selection through single nucleotide polymorphisms 
(Bigham et al., 2014; Mahmoud et al., 2015b). Therefore it has been hypothesized 
that the body through natural selection may be utilizing AMPK to synchronise 
responses arising from oxygen deficits (hypoxia) in animals and its  α1- subunit  is 
the principal mediator of this function (Evans, 2006; Mahmoud et al., 2015b).   
The β subunit contains two characteristic regions, a central (glycogen- binding) 
domain and a C-terminal domain (Hudson et al., 2003; Polekhina et al., 2003; Iseli et 
al., 2005; Townley and Shapiro, 2007; Viollet et al., 2010; Carling et al., 2012). The 
physiological role of the central domain is unclear, although it is found in enzymes 
that metabolise starch and glycogen and there is speculation that the domain could be 
involved in binding AMPK to glycogen, as well as providing a mechanism for the 
regulation of AMPK by glycogen (Hudson et al., 2003; Polekhina et al., 2003; 
Carling, 2004; Fryer and Carling, 2005; Viollet et al., 2010; Carling et al., 2012). The 




γ subunits (Hudson et al., 2003, Iseli et al., 2005; Fryer and Carling, 2005; Townley 
and Shapiro, 2007; Carling et al., 2012; see Figure 1.2). 
The γ-subunit contains a variable N-terminal domain that is followed by four 
domains which are known as CBS (cystathionine-β-synthase) domains (Bateman, 
1997; Fryer and Carling, 2005; Towler and Hardie, 2007; Viollet et al., 2010). The 
CBS domain in AMPK forms the adenine nucleotides (AMP, ADP, ATP)-binding 






1.2.2 Regulation of AMPK  
The activity of AMPK can be regulated via various ways and these include: 
Allosteric Regulation: 
In mammals, AMPK activity is allosterically activated by AMP (Emerling et al., 
2009; Viollet et al., 2010; Xiao, et al., 2011; Hardie, 2011; Carling et al., 2012). 
AMP binds to the regulatory γ subunit and this binding result in a 2 to 5 fold increase 
in the kinase activity (Hardie et al., 1999; Viollet et al., 2010; Carling et al., 2012). 
The nature of the  α and γ- isoforms that  make up the  AMPK complex, markedly 
affect the  level  of  its activation by AMP (Cheung et al., 2000; Viollet et al., 2010; 
Carling et al., 2012). It has been reported that complexes containing the γ3 isoform 
are weakly activated by AMP, while those containing the α2 and γ2 subunits show 
the greatest degree of activation (Cheung et al., 2000; Viollet et al., 2010). When 
AMP binds to the γ-subunit of AMPK, it leads to a change in the shape of the 
enzyme that indirectly affects its catalytic activity (allosteric activation) and this 
conformational change in the protein kinase also protects it from dephosphorylation 
by protein phosphatases, as well as promoting phosphorylation by upstream kinases 
(Davies et al., 1995; Suter et al., 2006; Sanders et al., 2007; Oakhill et al., 2010; 
Viollet et al., 2010). ATP in high concentrations, has been shown to antagonise the 
effects of AMP on AMPK (Davies et al., 1995; Hardie et al., 1999; Viollet et al., 
2010; Carling et al., 2011), indicating that it is a change in the intracellular 
AMP/ATP ratio, rather than the AMP concentration, that regulates AMPK activity 




Regulation via phosphorylation / dephosphorylaton: 
The major way of regulating AMPK activity is through reversible phosphorylation 
(Stein et al., 2000; Viollet et al., 2010; Xiao et al., 2011; Carling et al., 2012). The 
phosphorylation of the amino acid residue Threonine 172 of the α subunit, by 
upstream kinases activates AMPK (Stein et al., 2000; Emerling et al., 2009; Xiao et 
al., 2011; Carling et al., 2012; Miyamoto et al., 2015). The phosphorylation of 
Thr172, leads to a several-hundred-fold increase in the activity of AMPK (Suter et 
al., 2006; Sanders et al., 2007; Xiao et al., 2011). It has been reported that, the 
combination of the allosteric and phoshorylation activation of AMPK, produces more 
than a 1000- fold increase in its activity (Suter et al., 2006; Hardie, 2011). In 
mammalian cells, the principal upstream kinases that phosphorylate  (Thr172) 
AMPK, include the tumor suppressor kinase, LKB1 (liver kinase B1) and  
Ca
2+
/Calmodulin-dependent protein kinase kinase β (CaMKKβ) (Woods et al., 2003; 
Hawley et al., 2005;  Hurley et al., 2005; Woods et al., 2005; Viollet et al., 2010; 
Carling et al. 2011; Carling et al. 2012) . In addition to the above, a number of other 
upstream kinases may be involved in the phosphorylation of AMPK in vivo (Carling 
et al., 2008; Viollet et al., 2010).    
In vitro studies have shown that AMPK can be  de-phosphorylated by the protein 
phosphatases PP2A and PP2C (Davies et al. 1995; Viollet et al., 2010).The ability of 
the phosphatases to dephosphorylate AMPK at Thr-172 is inhibited when AMP binds 






Regulation by ADP 
Recent studies have shown that ADP also plays a role in the regulation of the activity 
of AMPK. ADP can bind to any one of two nucleotide (AMP/ADP/ATP) binding 
sites on the regulatory fragment of the AMPK complex (Xiao et al., 2011). This 
binding protects the enzyme from dephosphorylation, but does not lead to its 
allosteric activation (Xiao et al., 2011; Carling 2012). Previous studies have shown 
that in normal conditions AMPK mainly exists in its inactive form in a complex with 
Mg-ATP (Xiao et al., 2007, Xiao et al., 2011). The mammalian AMPK binds more 
tightly to ADP and AMP (about 10 –fold ) than to Mg-ATP, so despite the higher 
physiological concentration of Mg-ATP the competitive binding of either ADP  or 
AMP offsets the Mg-ATP from the regulatory binding sites of  the enzyme (Carling 
et al., 2011; Xiao et al., 2011).  Therefore under most conditions AMPK activity is 
regulated by the ATP: ADP ratio via changes in phosphorylation at Thr172 (Carling 
et al., 2011). However, during severe stress conditions, when the concentration of 
AMP is very high, the additional allosteric activation by AMP may function as a 
further device, which ensures that all AMPK molecules are fully phosphorylated 
resulting in maximum activation (Carling et al., 2011). 
 
 Regulation of AMPK at whole- body level 
Various hormones, cytokines, nutrients and substances play a role in the regulation 




where it acts as a central regulator of food intake by mediating various orexigenic 
and anorexigenic signals (Kola et al., 2006; Kola et al., 2008; Blanco et al., 2011). 
Studies have shown that AMPK activity in the hypothalamus increases during fasting 
and drop during refeeding (Minokoshi et al., 2004; Kola et al., 2008). Leptin, when 
administered in vivo results in a fall in hypothalamic AMPK activity and reduced 
food intake (Minkoshi  et al., 2004; Andersson et al., 2004) , while ghrelin, an 
orexigenic hormone on the other hand activates  hypothalamic AMPK and increases 
food intake (Andersson et al., 2004; Blanco et al., 2011). Other hormones include 
adiponectin which increases AMPK activity in the arcuate nucleus of the 
hypothalamus leading to increased feeding (Yamauchi et al, 2002; Blanco et al., 
2011; Hardie et al., 2012). Studies have also shown that anorectic hormones and 
factors such as cilliary neurotrophic factor, insulin, estradiol, glycogen-like peptide-1 
inhibit hypothalamic AMPK activity (Watt et al., 2006; Blanco et al., 2011), while 
orexigenic signals such as  glucocorticiods, cannabinoids  and the neuropeptide  
agouti-related protein increases hypothalamic AMPK activity (Blanco et al., 2011). 
Hypothalamic AMPK activity is also modulated by nutrients such as glucose, whose 
administration suppresses AMPK activity and citrate, lactate, and amino acids such 
as leucine which have inhibitory influences on AMPK activity resulting in 
anorexigenic responses (Blanco et al., 2011). 
AMPK plays a role in skeletal muscle metabolism, where it mediates the non-insulin 
dependent- glucose uptake in skeletal muscle cells during exercise (Merrill et al., 
1997; Kola et al., 2008).  AMPK mediates this action mainly in the glycolytic, fast-




al., 2008; Hardie et al., 2006).  In the liver, AMPK activation causes the inhibition of 
gluconeogenesis, fatty acid, triglyceride, cholesterol and protein synthesis, while it 
stimulates fatty acid oxidation (Kola et al., 2008).  In line with the above its 
activation in the adipose tissue causes decreased fatty acid uptake, decreased 
triglyceride synthesis and increased fatty acid oxidation (Kola et al., 2008).  
 
1.3 Literature Review Part 2: Oxygen-sensing in the carotid bodies 
In mammals the ventilatory response to hypoxia originates from the carotid bodies 
(Teppema and Dahan, 2010). The carotid bodies are small sensory organs located 
bilaterally within the carotid bifurcation (Kumar, 2007; Lopez-Barneo et al., 2009).  
It is now fully established that the carotid bodies are the primary peripherial arterial 
chemoreceptors, although the molecular sensor that couples decrease in oxygen 
tension during hypoxia to its activation is still unknown (Prabhakar, 2000; Prabhakar 
and Peng, 2004; Liu, et al., 2009; Lopez- Barneo et al., 2008). 
The afferent (sensory) nerve supply of carotid body is via the carotid sinus nerve 
(CSN), which is a branch of the glossopharyngeal nerve (cranial nerve IX), with its 
cell bodies located in the petrosal ganglion (Figure 1.3). The carotid body afferents 
project to the nucleus of the tractus solitarius (NTS) of the medulla in the brainstem, 
where information is integrated to control both cardiopulmonary and autonomic 
reflex responses (Kumar, 2007; Figure 1.3). 
 The efferent innervations to the carotid body include a sympathetic input from the 




vagus nerve (Kumar, 2007). The carotid body is a highly vascular organ, receiving 
its blood flow through a branch arising from the external carotid artery (Kumar, 
2007; Lopez-Barneo et al., 2008).  The capillary network across the carotid body 
consists of both the typical diameter capillaries (about 7-8 µm) and wider diameter 
penetrating sinusoid vessels  (18µm)  that  lie  in very close contact with  the type I 
cells (Kumar, 2007) . Apart from the capillary network, arterio-venous shunts are 
also present in the carotid bodies and these allow for multiple routes of blood flow 





, at normal blood gases and blood pressure), amounting to  
about 10-15  times that received by the brain, relative to its size (Kumar, 2007).  
The parenchyma of the carotid body is organised into clusters of cells (3-5 in each 
cluster) in intimate contact with capillaries and nerve fibers (glomeruli) (Kumar, 
2007; Lopez-Barneo et al. 2009).  Among the various cells types in the glomerulus, 
the most abundant ones are the neuron-like type  or glomus cells (8-12μm in 
diameter), and enveloping them are the processes of the sustentacular (glia-like) type 
 cells (Prabhakar, 2000; Kumar, 2007; Lopez-Barneo et al., 2009). Autonomic 
neurons and fibers which appear to have efferent regulatory action on the type 1 cells 
are also found in the carotid body (Lopez-Barneo et al., 2008). The type  cells have 
been  identified as the primary oxygen–sensing cells in the carotid body, while type 
 cells are regarded as being supportive in nature (Prabhakar, 2000; Prabhakar and 
Peng, 2004; Lahiri et al., 2006; Kumar, 2007; Lopez-Barneo et al., 2008, 2009). The 
type  cells also act as in vivo precursors of new glomus cells during hypoxic 




 The glomus cells contain secretory vesicles that are packed with a variety of both          
excitatory and inhibitory neurotransmitters and neuromodulators, which have been 
hypothesized to be involved in the chemosensory function of the carotid body 
(Nurse, 2005; Kumar, 2007; Lope-Barneo et al., 2008). These include amines (e.g 
dopamine, norepinephrine and acetylcholine), neuropetides (e.g substance P), purines 
(e.g ATP and adenosine), amino acids (e.g γ-aminobutyric acid (GABA) and gas 
signalling molecules (e.g nitric oxide and carbon monoxide) (Nurse, 2005; Kumar, 
2007; Lope-Barneo et al., 2008, 2009). Dopamine has been suggested to play an 
autocrine role in the function of the carotid body via its inhibition of the glomus cell 
Ca
2+ 
channels, while on the other hand ATP and ACh appear to be the main 
neurotransmitters that mediate the glomus cell–afferent chemo-transmission in the 
carotid body (Nurse, 2005; Lope-Barneo et al., 2009).  
 
1.3.1 Oxygen sensing in the carotid body 
 Almost all mammalian cells sense oxygen, but the carotid body is a specialised 
oxygen sensing organ that can detect and transduce modest falls in the partial 
pressure of oxygen in the arterial blood (PaO2) to a neural signal that is beneficial for 
the overall maintenance of oxygen homeostasis in the body (Prabhakar, 2000; 
Prabhakar and Peng, 2003; Lahiri et al., 2006; Kumar, 2007; Lope-Barneo et al., 
2008).   
 It is well established that the glomus cells are the chemoreceptive elements in the 




neurotransmitters that act on nearby sensory nerve fibers resulting in an increase in 
the afferent traffic through the carotid sinus nerve (CSN) (Prabhakar, 2000; 
Prabhakar and Peng, 2003; Lahiri et al., 2006; Lope-Barneo et al., 2008; Lope-
Barneo et al., 2009;   Evans et al., 2009; Lui et al., 2009).  The CSN  afferents project  
to the brainstem  where they  elicit appropriate adjustments in the breathing patterns 
until the partial pressure of oxygen (PO2) in the blood is restored  to normal 
(Prabhakar, 2000; Prabhakar and Peng, 2003; Lahiri et al.,2006; Lope-Barneo et al., 
2008, 2009;  Evans et al., 2009; Lui et al., 2009). Many classes of O2- sensitive K
+
 
channels are found in the glomus cells and it has been reported that during hypoxia 
their opening probability (modulated by an unknown oxygen transducer)  decreases 
resulting in the depolarization of the glomus cell membrane (Peers and Buckler, 
1995; Lopez-Berneo et al., 2001; Weir et al., 2005; Lopez- Berneo et al., 2008).  
Some of these channels include, the voltage –dependent K
+





 and the twin pore acid-stimulated K
+
  channel-like background 
channel (Lope-Barneo et al., 2008).  It is worth noting that  there are  species 
differences  in  the  type of O2- sensitive K
+
 channels that are expressed and also that 
within species there may  be an expression of  more than one  type of O2- sensitive 
K
+
 channels  (Peers et al., 2010) . Apart from K
+ 
channels the type 1 cells also 




channels (Lope-Barneo et 
al., 2009).                                      
 
The basic mechanism for the carotid body chemotransduction during hypoxia 
involves, the inhibition of specific K
+
 channels via the action of a molecular sensor 




firing rates of the cells resulting in Ca
2+ 
channel opening and transmembrane Ca
2+
 
influx into the cell, which elicits neurotransmitter release (Lopez- Barneo et al., 
2008, 2009; Peers et al., 2010). This basic sensory process of the carotid body 
chemotransduction during hypoxia is referred to as the membrane hypothesis for 
oxygen sensing (Lopez- Barneo et al., 2008; Peers et al., 2010). The generated neural 
signal is then conveyed through the CSN to the NTS in the medulla of the brainstem 
(Kumar, 2007). 
Although there have been great advances in understanding the cellular physiology of 
the carotid body, the molecular mechanisms (and/or sensor) that underpin the type1 
cell oxygen sensing (i.e. the precise mechanism(s) through which deviation in 
oxygen tension is translated into the inhibition of K
+ 
channel in the glomus cells) is 
still largely unknown (Wyatt and Evans, 2007; Lopez- Barneo et al., 2008; Peers et 
al., 2010). While several hypotheses have been put forward to explain this oxygen 
sensing mechanism(s) of the carotid body, the two principal ones are the 
mitochondrial hypothesis and the Membrane hypothesis (Lahiri et al. 2006; Wyatt 
and Evans, 2007). 
The mitochondrial hypothesis suggests a possible role of the mitochondria in the 
carotid body chemotransduction following  hypoxia and this is in line with the early 
findings of Heymans et al. (1931) that potassium cyanide stimulates respiratory 
reflexes when introduced into the carotid sinus, an effect similar to that which is 
observed during hypoxia (Wyatt and Evans, 2007). Cyanide is an inhibitor of 
mitochondrial complex IV (Lopez- Barneo et al., 2008) and several reports have 




mitochondrial uncouplers increase the afferent discharge of the carotid sinus nerve 
(Mills and Jobsis, 1972; Lopez-Barneo et al., 2008). Thus traditionally several 
investigators have considered the mitochondria  to be  the site of oxygen sensing in 
type  cells of the carotid body (Lopez-Barneo et al., 2008). On the other hand, the 
membrane hypothesis as earlier noted  explains that hypoxia causes the inhibition of 
specific K
+ 
channels in glomus cells leading to their depolarisation and a resultant 




influx which triggers the release of 
neurotransmitters (Urena et al., 1994; Buckler and Vaughan-Jones,1994;  Peers et al., 
2010). At present the membrane hypothesis is generally accepted, but there are many 
divergent views concerning how hypoxia leads to the inhibition of K
+
 channel 
activity (Peers et al., 2010) and thus there is an ongoing search for the oxygen sensor. 
One of such postulated O2 sensors is AMPK (Evans et al., 2005; Evans, 2006; Evans 
et al., 2009; Wyatt et al., 2007; Wyatt and Evans, 2007; Peers et al., 2010). The 
AMPK hypothesis, suggests that hypoxia increases the AMP/ATP ratio in the 
glomus cell as a result of metabolic stress and that this leads to the activation of 
AMPK, resulting in the inhibition of specific K
+
 (e.g BKca and leak K
+
) channels 
(Evans et al., 2005; Evans, 2006; Evans et al., 2009;  Wyatt et al., 2007; Wyatt and 
Evans, 2007; Peers et al., 2010). This hypothesis suggests a unifying basis between 
the mitochondrial and the membrane hypotheses (Wyatts and Evans, 2007; Peers et 
al., 2010). 
However recently the hypothesis that AMPK is necessary for the carotid body 
chemosensory response during hypoxia has fallen into disfavor, following the 




oxygen sensitivity and afferent discharge from the carotid body (Mahmoud et al., 
2015a,b). It is possible that other postulated O2 sensors such as Heme oxygenase -2 
may be the key players in mediating chemotransduction at the level of the carotid 
body (Lopez-Barneo et al., 2008; Peers et al., 2010). Interestingly though, in 
characterizing the response of AMPK- deficient mice to hypoxia, it was observed 
that these animals did show significant breathing disorders even though the carotid 
body function was normal. This suggests that AMPK deletion results in a hitherto 
unsuspected deficit in the central brainstem response to hypoxia despite a normal 
afferent input from the carotid body. The work in this thesis aims to further 




 1.4 Literature Review Part 3:  Central control of breathing by brainstem 
respiratory circuitry 
The principal point of termination of the chemosensory afferents from the carotid 
body is in the caudal regions of nucleus tractus solitarius in the brainstem (Teppema 
et al., 1997; Cruz et al., 2010; Alheid, et al., 2011; Smith et al., 2013; Zoccal et al., 
2014). The brainstem contains spatially and functionally organised neural circuits 
that generate breathing movements, which are innate, rhythmic motor patterns that 
occur automatically and continuously throughout life (Alheid et al., 2011; Smith et 




These brainstem neural circuits, which  make up the respiratory central pattern 
generator (CPG) consist of excitatory and inhibitory interneurons within a ventral 
respiratory column (VRC), that is located bilaterally on each side of the medulla 
(Alheid et al., 2011; Smith et al., 2013) (see Figure 1.4). Structures that make up the 
VRC include, the retrotrapezoid nucleus (RTN), the Botzinger (BotC) and Pre-
Botzinger (Pre-BotC) complexes, the rostral ventral respiratory group (rVRG) and 
the caudal ventral respiratory group (cVRG; Smith et al., 2013). These microcircuits 
in the respiratory CPG are in the other hand, modulated by several afferent systems, 
some of which include sensory information from caudal nuclei of the solitary tract 
(NTS; Smith, et al., 2013), as well as inputs from pontine  and supra-brainstem  
nuclei  e.g motor and sensory cortices, basal ganglia, cerebellum and hypothalamus 
(Smith et al., 2013). The efferent outflow from these circuits are relayed via 
premotor networks to the cranial motor neurons that innervate the upper airways as 
well as to the spinal motorneurons (phrenic,  intercoastal and lumbar) that supply the 
diaphragm, thoracic and abdominal pump muscles respectively ( Smith et al., 2013). 
Overall, the structures that make up the brainstem respiratory network are arranged 
bilaterally from the rostral pons to the caudal medulla and these include, the pontine 
respiratory group (PRG, comprising the Kolliker–Fuse (K-F) nucleus and the 
prabrachial nuclei), the retrotrapezoid nucleus/ parafacial respiratory group, the  
Botzinger complex, the pre-Botzinger complex, the rostral respiratory group, the 
caudal respiratory group, the nucleus tractus solitarius and the brainstem raphe nuclei 




The NTS is located in the dorsomedial portion of the medulla oblongata and is made 
up of  heterogeneous groups of neurons, including catecholaminergic neurons that 
serves as critical integrating sites in control of breathing (Buller et al., 2008; Alheid, 
et al., 2011; Zoccal et al., 2014). The NTS acts as an entry point for multiple sensory 
afferents such as the pulmonary mechanoreceptor, peripheral chemoreceptor (carotid 
body) and other visceral sensory afferents (Alheid et al., 2011; Smith et al., 2013; 
Zoccal et al., 2014).  Studies have shown that the caudal NTS regions (cNTS) 
alongside with the associated dorsal respiratory group (DRG) are involved in 
mediating the afferent control of breathing through their projections to the pontine 
and VRC components of the brainstem respiratory network (Alheid, et al., 2011; 
Smith et al., 2013; Zoccal et al., 2014).  
The caudal NTS contains well–defined neurochemical cell groups, particularly the 
A2 noradrenergic neurons which along with the close by C2 adrenergic neurons play 
major roles in respiratory control (Buller et al., 2008). Additionally in the 
ventrolateral medulla (VLM) are distinct populations of catecholaminergic neurons 
namely, the A1 noradrenergic neurons and the C1 adrenegic neurons (Buller et al., 
2008), which form part of the respiratory central pattern generator.  The importance 
of these catecholaminergic neuronal groups in the control of respiration is 
emphasized for example by the profound disorders of breathing seen in Rett 
syndrome, associated with a loss of central catecholaminergic neurons. The Rett 
syndrome is an X-linked neurodevelopmental disorder that occurs in females and is 
caused by mutation of the methyl CpG binding protein 2 (MECP2) gene, which 




Stettner et al., 2007; Smith 2013). Patients with Rett syndrome suffer from 
bioaminergic deficiencies (noradrenalin and serotonin), and display episodes of 
breath-holding and life-threatening breathing arrhythmias which may result in 
sudden death (Viemari et al., 2006; Stettner et al., 2007; Roux and Villard 2010; 
Smith 2013). It has been reported that twenty–six percent of the deaths that occurs in 
girls with Rett syndrome could be attributed to the sudden respiratory arrhythmia that 
occurs in these patients (Viemari et al., 2006; Stettner et al., 2007). Several studies 
using  mouse models  in which  the  MECP2 gene has been knocked-out (mecp2-/y)  
has been carried out to  uncover the  origin of these respiratory  abnormalities 
(Viemari et al., 2006; Smith 2013).  Mecp2-/y mice at birth showed normal breathing 
and normal number of TH neurons in the medulla, but at about one month of age 
there was a variability in the duration of respiratory cycles coupled with a significant 
reduction in the number of medullary TH neurons and noradrenalin content which 
progressed into severe respiratory disturbances including high variability in breathing 
cycle period and frequent apneas. Finally a fatal respiratory arrest occurred at about 
two months of age with a drastic reduction in the numbers of TH neurons, 
noradrenalin and serotonin (5-HT) content in the medulla (Viemari et al., 2006). 
Thus a deficit of the catecholaminergic and serotonergic modulation of the medullary 
respiratory network, is believed to result in an excessive expiratory activity, and 
profound abnormalities in breathing pattern (Viemari et al., 2006; Stettner et al., 
2007; Smith 2013). 
A more detailed description of the A1/C1 and A2/C2 catecholaminergic neurons and 




In contrast to hypoxia, ventilation during normal conditions is driven by changes in 
the partial pressure of carbon dioxide (CO2) and pH of the blood and cerebrospinal 
fluid.  These stimuli are detected by central chemoreceptors (with varying degree of 
chemosensitivity) located in multiple areas in the brainstem as well as in the 
cerebellum (Nattie, 1999; Putman et al., 2004; Dean and Nattie, 2010).  Changes in 
blood pCO2 and pH are also sensed by peripheral chemoreceptors in the aortic and 
carotid bodies, and their afferent projections to the brainstem respiratory neurons 
contribute to the control of breathing during normal conditions (Nattie, 1999).  
In mammals the normal value for the arterial pCO2 is 40mmHg at blood pH of 7.4 
and small increases above this value produce dramatic increases in ventilation, while 
on the other hand small decreases in pCO2 below the normal value can decrease 
breathing to apnea as may be observed during anesthesia and sleep (Nattie, 1999).      
Overall, although the control of respiration during eupneic (normal) breathing is 
largely understood the regulation of ventilation during hypoxia remains controversial 
and moreover there is limited information with regard to the location and cellular 
mechanisms of oxygen sensing neurons in the brainstem (Neubauer and Sunderram, 
2004).  In this thesis I look at the possible location(s) of these neurons and the 












Figure 1.1 : Activation of AMPK by hypoxia and other metabolic stressors. 
Hypoxia and other stressors such as ischemia and muscle contraction 
leads to a fall in the cellular ATP levels, while causing  a rise in cellular 
AMP level and this activates the AMPK either directly (allosteric 
activation) or indirectly via phosphorylation by upstream kinases. Once 
activated AMPK accelerates all ATP producing pathways while inhibiting 
all ATP-consuming pathways. Thus AMPK activation preserves the 


















 Figure 1.2 : Organization of the AMPK (α, β and γ) subunit domains. 
Threonine 172 residue phosphorylated by LKB1, CaMKKβ and TAK1 is 
shown within the α-subunit. The CBS domains also called the Bateman 






Figure 1.3: Diagram showing the anatomical location of the carotid bodies 
with their sensory innervation. Carotid bodies are located bilaterally at the 
bifurcation of the common carotid arteries. Their sensory nerve supply is 
via the glossopharyngeal nerve (sinus branch) which transmits 
















Figure 1.4:  A parasagittal section through one side of the rat brainstem showing 
the bilateral distribution of the brainstem respiratory network arranged from the 
rostral pons to the caudal medulla. Areas of predominant inspiratory, expiratory, 
tonic and respiratory modulated (phasic) interneurons are indicated.  The nucleus 
tractus solitarius (NTS) in the dorsal brainstem strongly modulates the activity of 
the neural pattern generators in the ventral respiratory column (VRC).  
Abbreviations are as stated in the list of abbreviations page. (Adapted from Smith 







Activation of brainstem areas during hypoxia in AMPK deficient mice 
 
2.1 Introduction  
Previous studies in experimental animals such as rats and rabbits have identified 
neuronal populations, associated with the control of breathing, in the brainstem that 
are activated in response to a hypoxic stimulus (Erickson and Millhorn, 1994; 
Teppema et al., 1997; Hirooka et al.,1997). In this Chapter I investigated the 
activation upon exposure to hypoxia of brainstem areas in AMPK DKO mice, in 
comparison to DFlox control mice, using c-Fos as a neuronal marker of activation, 
with the aim of identifying any differences in DKO animals that may underlie the 
hypoxia-induced hypoventilation and apnoeas seen in these animals. 
The aim of these experiments was to identify specific areas of the brainstem where 
the deletion of AMPK in TH+ve neurones, leads to a change in their response to the 
hypoxic stimulus, which may then be associated with the abnormal hypoxic response 
seen in the DKO animals. 
2.1.1 c-fos 
The most widely used neuronal activation marker in vivo is Fos, the protein product 
of the immediate -early gene c-fos (Sagar et al., 1988; Hoffman et al., 1993., Thiele 
et al., 2000, Morgan and Curran, 1991; Kovacs, 1998; Han et al., 2003). c-fos is a 
member of the two proto-oncogenes families consisting of the fos family (c-fos, 
fosB, fra-1 and fra-2) and the jun family (c-jun, junB and junD) which are referred to 
as cellular immediate-early genes, because a variety of extracellular stimuli cause 
their rapid and transient induction (Pelto-Huikko et al., 1995 Kovacs, 1998). c-fos is 




gated calcium entry into the cell in response to electrical , chemical or environmental 
stimuli (Peng et al., 1995; Han et al., 2003). The transcription product of c-fos, the 
Fos protein is regarded as a messenger molecule that couples short term extracellular 
signals with long term changes in cell function after neuronal activation (Han et al., 
2003). When neurons are not activated the transcriptional activity of the c-fos gene is 
low with a resultant low level of the Fos protein production and thus an increase in 
cfos expression following stimulation is an indication of neuronal excitation 
(Hoffman et al., 1993; Thiele et al., 2000).  
It is worth noting that c- Fos was the first to be characterized among the Fos family 
of proteins and it forms complexes (dimers) with other members of the Fos and Jun 
protein families (Hoffman et al., 1993; Gao and Ji, 2009). Such complexes include 
the c-Fos/c-Jun and c-Fos/Jun B dimers (Hoffman et al., 1993; Gao and Ji, 2009). 
These complexes bind to AP-1 sites on the DNA to induced gene transcription and 
thus c- Fos is involved in a signal transduction network that connects extracellular 
events to intracellular changes (Hoffman et al., 1993; Gao and Ji, 2009).  The 
binding of these complexes to the AP-1 specific binding sites on the DNA is 
responsible for the nuclear staining that is observed during the localization of c-Fos 
or c-Jun via immunocytochemistry (Hoffman et al., 1993). At the cellular level c-fos 
expression can be studied either with the detection of c-fos mRNA via in situ 
hybridization, or through its nuclear phosphoprotien Fos, using 
immunohistochemistry (Peng et al., 1995; as in this work, see Results). Studies have 
shown that maximal c-Fos protein expression is achieved at 60- 90 minutes after 
exposure to stimuli and persists for 2-5 hours, while the cellular level of the c-fos 
messenger RNA peaks at 30- 60 minutes before declining to basal levels at 180 




The use of c-Fos as a marker for neuronal activation is further advantageous since 
Fos is found in the nucleus, and it is possible to identify the phenotype of the 
activated neurones through substances located in their cytoplasm with the use of 
double-labelling immuno-histochemical techniques (Gao and Ji, 2009; Hoffman et 
al., 1993). Moreover c-Fos immuno-histochemical procedure is relatively easy to 
carry out using commercially available antibodies and can be quantified (Gao and Ji, 
2009). However there are also some limitations in the use of c-Fos as a neuronal 
activation marker. c-Fos may not be valuable as an investigating tool for inhibitory 
systems, or systems with reduced tonic activity, since it is typically expressed 
following excitation. Also persistent or recurring (chronic) stimuli do not lead to c-
Fos expression, thereby hindering the elucidation of neuronal activation in such 
conditions (e.g. during suckling, Hoffman et al., 1993). It is believed that when 
neurons are repeatedly stimulated they may activate intracellular mechanisms that 
result in the inhibition of chronic c-Fos expression. A few other pitfalls include the 
possibility that a neuronal population may express another immediate early gene 
product and not necessarily c-Fos when stimulated, and that the threshold for c-Fos 
induction may differ from neuron to neuron, and the induction of c-Fos in a given 
neuron may be dependent on the activating neurotransmitter or second messenger 
involved (Hoffman et al., 1993). In spite of the foregoing, c-Fos is still widely 
accepted and used as a robust marker for neuronal activation. Studies have shown 
that other immediate–early gene proteins such as members of the Jun protein family 
(e.g c-Jun) and Fos-related antigens (FRAs) can also serve as markers for neuronal 






2.1.2 Brainstem areas activated by hypoxia 
Previous studies using the expression of c-Fos as an index of neuronal activation 
have shown that single and chronic–intermittent exposure to hypoxia in various 
experimental animals, results in Fos-like immunoreactivity in discrete brainstem 
areas associated with the integration of visceral (including respiratory) sensory 
inputs (Sica, et al., 2000). 
The classical works of Erickson and Millhorn (1994) and Teppema et al.(1997) in 
rats and that of Hirooka et al.(1997) in rabbits have clearly identified specific 
brainstem areas that are activated following hypoxia. Exposure of these animals to a 
single episode of moderate hypoxia (7-10% O2; balanced with N2) resulted in the 
distribution of c-Fos in the following brainstem areas: 
Medulla. 
 In the medulla c- Fos immunopositive neurons were found bilaterally in the NTS, 
predominantly in the commissural, medial and dorsomedial subdivisions of the NTS 
(including the SubP region), with some labelling in the ventrolateral portion 
(Erickson and Millhorn, 1994; Teppema et al., 1997; Hirroka et al.,1997). Fos–like 
immunoreactive neurons were also present in the area postrema (AP) and in the 
intermediate reticular formation (Erickson and Millhorn, 1994; Teppema et al., 1997; 
Hirooka et al., 1997). 
c-Fos was also expressed bilaterally in many neurons located throughout the 
rostrocaudal length of the ventrolateral medulla (VLM). In the caudal VLM the 
majority of the c-Fos immunopositve cells were located in and close to the A1 
noradrenergic neuronal group (Erickson and Millhorn, 1994; Teppema et al., 1997; 




areas surrounding the nucleus ambiguus with the highest density in the ventrolateral 
part (Hirooka et al., 1997). In the rostral VLM including the C1 region, c-Fos 
immunopositive cells were present mainly in the retrofacial paragigantocelullar 
nucleus (Teppema et al., 1997; Hirooka et al., 1997). Other areas in the medulla that 
have been reported to show Fos-like immunoreactivity following hypoxia include 
the raphe nuclei, the gigantocellular nucleus, the parapyramidial region in rostral 
medulla, the cochlear nucleus and in anesthetized rats, the medial vestibular nucleus 
(Erickson and Millhorn, 1994; Teppema et al., 1997; Hirooka et al.,1997). 
Pons 
In the pons an array of cells were also shown to express c-Fos in experimental 
animals upon exposure to hypoxia. c-Fos immunoreactive neurons were present in 
the parabrachial complex and the Kolliker-Fuse nucleus, the locus coeruleus and 
subcoerulus region (Erickson and Millhorn, 1994; Teppema et al., 1997; Hirooka et 
al.,1997). Immunopositive cells were equally encountered bilaterally in the A5 
noradrenergic cell group in the caudal ventrolateral pons as well as in the raphe 
magnus nucleus (Erickson and Millhorn, 1994; Teppema et al., 1997; Hirooka et al., 
1997).  
Studies have also shown that experimental animals exposed to a paradigm of chronic 
intermittent hypoxia expressed Fos-like immunoreactivity in similar brainstem 
nuclei as discussed above (Greenberg et al., 1999; Ma et al., 2008). 
 c-Fos and TH neurons in the brainstem 
As discussed in Chapter 1, brainstem catecholaminergic neurons play an important 
role in the control of respiration with a net excitatory effect on ventilation (Li and 




abnormalities including breath-holding, apnoeas and a loss of the drive to breathe, in 
Rett syndrome. The activation of catecholaminergic neurons following hypoxia in 
different regions of the brainstem has also been characterized, using double 
immunohistochemistry for c-Fos and tyrosine hydroxylase (TH), which is the rate-
limiting enzyme in the biosynthesis of catecholamines. Hirooka et al. (1997) showed 
that upon exposure to hypoxia one quarter of the c-Fos immunoreactive cells in the 
NTS were immunopositive for TH, while half of c-Fos expressing cells in the VLM 
also stain for TH, amounting to 45% - 65% of all the TH+ve neurons in this region. 
These observations were similar to the earlier results of Erickson and Millhorn 
(1994), where they observed co-localization of c-Fos and TH-immuno positive 
staining both in the A2/C2 and A1/C1 neuronal groups in rats that were exposed to 
hypoxia.  
In this study, I therefore investigated the response of brainstem TH+ve neurones to 
hypoxia, to determine if the breathing disorders observed in the AMPK DKO 
animals were due to differences in the numbers or activation of TH+ve neurones 
during hypoxia. 
 
2.2   Materials and Methods 
2.2.1 Animals 
AMPK mutant mice weighing between 31-43g (8-10 weeks old) were used for 
experiments in this thesis. All mice (a gift from Prof. Mark Evans, with the mice 
colony under the management of Dr. Oluseye Ogunbayo) were bred and housed in 
the BRR animal facility, Centre for Integrative Physiology, School of Biomedical 




with the University of Edinburgh guidelines for animal research and in conformity 
with the UK Animals (Scientific procedures) Act 1986. 
2.2.2 Generation of AMPK deficient mice 
In this work I compared the response to hypoxia of mice in which the α1- and α2- 





), with controls in which the α1- and α2- encoding genes of AMPK 





). I also compared the response to hypoxia of animals in which 





), in order to determine the role of the α2 isoform of 
AMPK in the hypoxic response. All the transgenic AMPK mice used in this work 
were kindly provided by Prof Mark Evans, Centre of Integrative Physiology, 
University of Edinburgh. The breeding programme, genotyping and maintenance of 
the colony of transgenic animals were carried out by members of the Evans 
laboratory (Mahmoud et al 2015a).  
In the DKO mice, conditional deletion of the α1 and/or α2 AMPK genes was 
achieved using the Cre-recombinase conditional gene targeting technique. Basically 
this technique is carried out by first generating a transgenic mouse line in which two 
loxP sequences in the same direction are added to the ends of the target gene (Floxed 
mice). To achieve unconditional deletion of the target gene, the Floxed mice can 
then be cross-bred with mice carrying the Cre-recombinase gene. The Cre-
recombinase recognizes the loxP sites in the DNA and excises the DNA segment 
between them (Metzger and Chambon, 2001; Kos, 2004; Gaveriaux-Ruff and 




However, as in this work, this strategy can also be used to produce conditional 
knockout of the targeted gene(s) in specific tissues, by the fusion of the Cre-
recombinase gene with a suitable tissue-specific promoter. The Cre-recombinase is 
therefore activated conditionally after birth (Metzger and Chambon, 2001; Kos, 
2004; Gaveriaux-Ruff and Kieffer, 2007; Deng, 2012; Miao, 2013).  
In this work, DFlox mice were used where both the α1- and α2- domains of the 
AMPK gene were flanked by loxP sequences and α2-Flox mice where only the α2-
domain was flanked by loxP sequences. These animals were cross-bred with mice in 
which Cre-recombinase was coupled to a promoter for tyrosine hydroxylase (TH; 
TH-Cre mice), to generate animals in which Cre-recombinase was expressed 
selectively in catecholaminergic, TH-expressing cells. Mating of DFlox mice with 
TH-Cre mice resulted in litters which included animals in which both the α1- and α2- 
subunits of AMPK were deleted (DKO mice), and mating of α2- Flox mice with TH-
Cre mice resulted in litters which included animals in which only the α2- subunits of 
AMPK were deleted (α2-KO mice). The genotype of each of the animals used in this 
work was confirmed by direct PCR of DNA samples extracted from ear or tail clips 
from the mice after weaning, to confirm the deletion of the target genes in each case 
(procedures carried out by members of the Evans laboratory, Centre for Integrative 
Physiology; Mahmoud et al 2015a). 
The success of the deletion of the AMPKα1 and /or α2 cataytic subunits in tyrosine 
hydroxylase expressing cells was confirmed by performing single cell end point 
reverse transcription- polymerase chain reaction (RT-PCR)  on isolated carotid body 
type 1 cells and adrenomedullary chromaffin cells and also by whole brain 
quantitative real –time PCR( qPCR) (Mahmoud et al., 2015a, b).The initial step in 




(NCBI) to target the excised regions of the AMPK gene which included; exons 4-7 
of the AMPKα1 gene and exons 5-7 of the AMPKα2 genes and thereafter the 
validity and the specificity of these primers were tested against complement DNA 
(cDNA) of the adrenomedullary chromaffin cells from wild type mice (C57/BL6) to 
ascertain that only single amplicons with the expected band length were generated 
(Mahmoud et al., 2015a).  These primers were designed because pre-designed 
primers from Qiagen for the AMPK α-subunits were not used due to the fact that 
they detect areas of the genes that are not within the floxed loxp sites which may 
results in the appearance of false positives if mRNA transcript is still produced 
regardless of whether the catalytic domains have been excised (Mahmoud et al., 
2015a) 
In carrying out single cell end point RT-PCR, amplification was achieved by adding 
GoTaq DNA polymerase (Promega) to 2.5μl of cDNA that was obtained from 
individual cells (including carotid body type 1 cells from wild type and AMPK 
transgenic mice as well as those of the wild type adrenomedullary chromaffin cells). 
The procedure was carried out in parallel with positive and negative controls. 
Positive controls were the samples from wild type adrenomedullary chromaffin cells 
while the negative controls included aspiration from the extracellular medium used 
during the collection of the cells, PCR controls and control aspirants, lacking reverse 
transcriptase (Mahmoud et al., 2015a, b).  









for 30s before proceeding to the 




45s and an extension stage for 60s at 72
 o
c which was 




c. 15 cycles were carried out 




detect the expression of tyrosine hydroxylase in both the carotid body and 
adrenomedullary chromaffin cells primers obtained from Qiagen (Quantitect Primer 
Assay, QT00101962) were utilized with an expected band length of 92bp while on 
the other hand AMPK was detected by using two primers, forward and reverse to 
generate the expected band length of 92bp (Mahmoud et al., 2015a, b). 15μl sample 
together with a 100bp DNA ladder (GeneRuler
TM
, Fermentas) were run on 2% 
agarose gels that was made with SYBR®Safe DNA Gel stain (Invitrogen). The gels 
were imaged with the use of a Genius Bio Imaging system and GeneSnap Software 
(Syngene). The RNA for both the isolated carotid body type1 cells and 
adrenomedullary chromaffin cells were extracted using the High pure RNA Tissue 
Kit (Roche) in accordance with the manufacturer’s guidelines and the concentration 
was determined by the use of the Nanodrop 1000 spectrophotometer 
(Thermoscientific).  cDNA synthesis was performed by the use of Transcriptor High 
Fidelity cDNA kit (Roche) in accordance with the manufacturer’s guidelines 
(Mahmoud et al., 2015a, b). 
  For the brain tissue, RNA extraction and cDNA synthesis were carried out using 
the same techniques as stated above.  The qPCR was performed by the method 
outlined in Mahmoud et al. (2015 b); 2.5 μl of  cDNA in RNase free water was made 
up to 25μl by the addition of FastStart  Universal SYBR Green Master (ROX, 12.5 
μl,  Roche), 8μl of Ultra  Pure Water ( Sigma) and forward and reverse  primers for 





optical 96-well Reaction Plate (Greiner bio-one), the plate was 
sealed with an optical adhesive cover (Applied Biosystems) and then centrifuged. 
The reaction was thereafter run on a sequence detection system (Applied 






c that was followed by a second step of 10 min at 95
 o
c and then a 15s step at 95
 
o
c ( this step was repeated 40 times). These were followed by a dissociation stage 
which consisted of a 15s step at 95
 o
c followed by a 20s step at 60
 o
c and finally a 
15s step at 95
 o
c.   
The negative controls that were used included as in  RT-PCR,  cell aspirants to 
which no reverse transcriptase was added, PCR controls and aspiration of the 



















In this work I utilized a barometric unrestrained whole- body plethysmography 
(UWBP) to determine the ventilatory responses of the DKO, α2-KO and DFlox mice 
to hypoxia.  
UWBP is non-invasive technique that allows for precise and quantitative 
measurements of respiratory parameters such as tidal volume, breath frequency and 
minute ventilatory volume (DeLorme and Moss, 2002; Glaab et al., 2007; Lim et al., 
2014). This procedure involves placing a mouse in a closed chamber and recording 
the pressure fluctuations that occur during the breathing cycle. The instrument 
consists of two chambers, the main chamber where the mouse is placed and a 
reference chamber. And with the help of a pressure transducer the pressure 
differences between the main chamber and the reference chamber are assessed 
during the breathing cycle (DeLorme and Moss, 2002; Glaab et al., 2007; Mahmood 
2015a; Figure 2.2). This procedure is useful because it overcomes the challenges of 
using anesthesia or restraints which are employed in invasive methods of assessing 
respiratory functions such as invasive plethysmography (DeLorme and Moss, 2002; 
Glaab et al., 2007; Lim et al., 2014). Anesthesia suppresses ventilatory functions, 
alter heart rate and is challenging to control while restraints can elicit an increase in 
ventilation due to additional stress (Lim et al., 2014). 
Plethysmography recording 
For this work, mice were placed in the main plethysmography chamber (Buxco 




movements of the mice relative to the reference chamber were recorded using a 
Halcyon low-noise pneumotachograph, and FinePointe acquisition and analysis 
software (Buxco Electronics Inc, USA). The experimental protocol consisted of an 
initial exposure of mice to 10 minutes of normoxia in the plethysmography chamber 
(Medical grade air; delivered at a flow rate of 3L/min to the main chamber), 
followed by another 10 minutes of exposure to a single episode of hypoxia (8% O2, 
0.05% CO2, balanced with N2). The plethysmograph and associated software 
produced an output file of pressure values recorded every millisecond, and a log of 
breath frequency, tidal volume, and minute ventilation values averaged over 
successive 2 second periods. The pressure values were analysed using scripts written 
in Python by Professor Mayank Dutia. The pressure values were plotted as for 
example in Figures 2.3 – 2.6, and the inter-breath intervals were measured. Apnoeas 
were identified in these recordings as inter-breath intervals which were greater than 
0.6 sec, as shown for example in Figures 2.4 – 2.6.                                                
Processing of brain tissue for immunohistochemistry  
Upon completion of the plethysmography protocol and the single exposure to 
hypoxia, the mice were returned to their home cages for ninety minutes to allow for 
c-Fos expression. At the end of the ninety minutes the mice were administered an 
overdose of sodium pentobarbital (0.2ml i.p.; Pentojet, Animal Care Ltd, York, UK) 
and transcardially perfused with heparinised saline (prepared by dissolving 129mg of 
heparin (Sigma- Aldrich, UK) in 1000mls of normal saline; approx. 120 mls, 
administered over 10mins) followed by fixation with 4% paraformaldehyde in 0.1 
phosphate buffer (approx.100ml; administered over 10mins; pH 7.4) with the use of 
a peristaltic pump. The brain was then dissected out en bloc and post-fixed overnight 
in vials containing 15% sucrose in 4% paraformaldehyde at 4
o




then cryoprotected by immersing them in 30% sucrose in 0.1M phosphate buffer at a 
temperature of 4
o
C for 24 hours, until the brains sank. They were then frozen in dry 
ice in tin foil. Coronal brainstem sections were subsequently cut using a freezing 
microtome (Leica CM 1325, Leica, set at - 17 to -18
o
C.) at 44µm. Alternate 
brainstem sections from each mouse were collected in two pots that were filled with 
0.1M phosphate buffer. The sections were then stored at -20
o
C in cryoprotectant 
(Ethylene glycol/glycerol in 0.2M phosphate buffered saline, PBS) for 
immunohistochemistry. 
 
Immunohistochemistry (c-Fos and tyrosine hydroxylase immunofluorescence) 
Cryoprotected sections were processed for both c-Fos and TH immunoreactivity 
following the protocol described below. This protocol is well established in our lab 
and has been developed by Dr Vicky Tobin, Dr. Nancy Sabatier and others for use in 
a variety of brain areas. 
The sections were first of all washed 4 times (10 mins per wash) in 0.1M phosphate 
buffer by the use of cell strainers inserted in to 6 –well plates placed on a shaker at 
room temperature. This was followed by incubation in 0.1M glycine diluted in 0.1M 
Phosphate buffer (PB) for 30mins to stop the fixation reaction of paraformaldehyde 
after which the sections were again exposed to another washing phase comprising of 
four washes of 10 mins each. This was followed by incubation with 3% normal goat 
serum (NGS) in 0.1M phosphate buffer with 0.3% Triton X-100 (PB-T) for 30 mins 
to block non-specific binding. Triton X-100 was added to enhance tissue penetration 
of the antibodies. Thereafter sections were incubated in primary antibodies (anti–Fos 




1: 50000 for anti–Fos rabbit polyclonal, Synaptic Systems, Gottingen, Germany and 
anti- tyrosine hydroxylase , raised in mouse, used at 1: 1000, Millipore, Ternecula, 
CA, USA) diluted in PB-T with 3% NGS . The sections were left overnight on the 
shaker at 4
o
C. Following this the sections were washed four times (15 mins each) 
with 0.1M PB and then incubated for 1 hour in biotinylated secondary anti–rabbit 
antibody raised in goat ( 1:500; Vector Laboratories, Inc, Burlingame, CA, USA) 
diluted in a mixture of 0.1M PB with 0.05% Tween which served to amplify the c-
Fos staining. The sections were again washed with 0.1M PB for four times with a 15 
minutes duration per wash before being incubated for 1 hour in vials containing 
secondary conjugated antibodies (Alexa Flour® 488- Streptavidin and Alexa Flour® 
568; (Molecular Probes, Inc.) Life Technologies, Oregon, USA, used at 1: 500) 
diluted in a mixture of 0.1M PB with 0.05% Tween. The final washing of the 
sections was then carried out (4 times; 15 mins per wash) and the sections were 
mounted serially onto gelatinized microscope slides, coverslipped using Vectashield 
hard set mounting medium (Vector laboratories Inc. Burlingame, CA, USA) and left 
to dry for 1 hour at room temperature before being wrapped in foil and kept in the 
dark at 4
o
C to preserve the fluorescence signal. It is worth noting that from the stage 
at which the secondary antibodies were added the sections were protected from light 
to prevent bleaching of the immunofluorescence signal.  
Microscopy and brainstem areas of interest 
After about 12-15 hours images of the brainstem sections were acquired using a 
Leica digital camera, controlled by Leica acquisition software (AIS) attached to an 
upright Leica microscope (LEICA DMR). Images were captured with both x10 and 





c-Fos and/or TH-immuolabelled neurons in the brainstem areas of interest were 
counted using Image J software (Fiji ; an open source platform for biological –image 
analysis).  The brainstem areas of interest included the caudal NTS with its 
subdivisions (SubP, Medial, ventral and ventrolateral, all of which contain the A2 
noradrenergic cells) as well the rostral NTS containing the C2 adrenergic neurons 
and regions of the ventrolateral medulla containing both the A1 and C1 
catecholaminergic neurons (see Results, below for further details of the regions of 
interest). C-Fos +ve and double-labelled neurons in the central (widest) area of each 
neuronal group were counted in the alternate brainstem sections for each mouse. The 
counts from each region of interest per section were normalized using the area of the 




Values in texts and tables are presented as mean± SEM, except where otherwise 
stated. Statistical comparison between groups was carried out with the use of 
GraphPad prism 6. A one-way ANOVA statistical test was used to ascertain the 
statistical differences between groups and this was followed by Tukey’s post hoc test 
to determine the actual differences between each of the groups. P ≤0.05 was 
considered to be statistically significant. 
 
2.3 Results  
2.3.1 Ventilatory response of mice following exposure to hypoxia 
Baseline recordings 
The breathing patterns of the control DFlox mice in normoxia, recorded in the first 




periods of regular normal breathing but these were frequently interrupted by 
irregular, high-frequency patterns of pressure changes in the plethysmography 
chamber which were due to the mice moving around, sniffing, and exploring the 
novel chamber, as exemplified in the recording from one animal shown in Figure 
2.3. These observed patterns made it difficult in almost all cases to obtain resting 
(baseline) values for breathing parameters (frequency, tidal volume, minute 
ventilatory volume), that could be used as a standard for comparing respiratory 
deviations upon exposure to hypoxia.  
This was in contrast to the previous work of Mahmood (2015a), where baseline 
breathing parameters were successfully obtained for each of the mouse groups 
(DFlox, DKO and α2-KO) by training each mouse, via repeated exposures to the 
plethysmography chamber to become accustomed to the chamber, and the breathing 
patterns were recorded only after the animals had settled down (e.g. 20 - 30 minutes 
or longer after being placed in the chamber). Interestingly there was no statistical 
difference in the baseline respiratory parameters between the three groups of animals 










Table 2.1: Baseline respiratory parameters in DFLox, DKO and α2-KO mice 
 
Since the aim of the present study was to compare patterns of c-Fos expression in the 
brainstem after a standardised protocol of exposure to hypoxia, the same for each 
animal, baseline values for the respiratory parameters in these animals were not 
obtained. Instead, in this work each mouse was exposed to hypoxia after the fixed 
normoxia period (10mins) without necessarily waiting to obtain a baseline breathing 
record. The more reliable resting values obtained by Mahmoud (2015a) for each 
group of animals were used to give the baseline against which the response to 
hypoxia was compared (e.g. Figure 2.7).    
Very shortly after exposure to hypoxia (i.e. switching the air flow inlet valve from 
Medical grade normal air (21% O2  with 0.05% CO2, balanced with N2) to the 
hypoxic gas mixture (8% O2 with 0.05% CO2, balanced with N2), the animals 
stopped exploratory and other behaviours and typically kept still or lay down on the 
floor of the plethysmography chamber.  This enabled clean breathing records to be 
obtained uncontaminated by the movement artifacts that were seen in the normoxia 
GROUP  FREQUENCY 
(breaths/min)  
TIDAL VOLUME  






 DFLox 215.9 ± 1.9 0.3631 ± 0.01 79.52 ± 2.7 31 
DKO 211.2 ± 2.5 0.3574 ± 0.02 74.62 ± 2.4 22 




period (see Figures 2.4 – 2.6). The switching of the gas mixture created a large 
pressure artifact in the plethysmograph recordings. The recordings shown in Figures 
2.4 – 2.6 begin immediately after the end of this pressure artifact, so that time 0 in 
these Figures corresponds to the start of the exposure of the animals to the hypoxic 
gas mixture.  
Upon exposure to hypoxia DFlox mice displayed an initial hyperventilatory response 
over the first minute or more of hypoxia (Figure 2.4, upper three panels). This was 
followed by a prolonged period of steady hypoxic breathing at a slower rate, with 
occasional larger breaths presumably corresponding to gasps (Figure 2.4).  With 
continued hypoxia, the animal showed a number of clear short apnoeas which 
followed a gasp, indicated by asterisks in Figure 2.4. 
By contrast, AMPK DKO mice upon exposure to hypoxia showed an initial  
hyperventilatory response similar to DFlox animals, but typically containing more 
irregular breathing such as the short sequences of larger and more frequent breaths 
shown in Figure 2.5 (upper two panels). Soon after this initial hyperventilatory 
response, the DKO animals typically developed frequent, long-lasting apnoeas 
(Figure 2.5, indicated by asterisks). These apnoeas were markedly longer than those 
seen in the DFlox animals (Figure 2.4).  
In AMPK α2-KO mice, exposure to hypoxia evoked an initial hyperventilatory 
response similar to the pattern observed in the DFlox mice (Figure 2.6).This was 
followed by a period of steady hypoxic breathing throughout the rest of the 
experiment, which was interrupted with short apnoeas, that tended to be more 
frequent in some animals than those typically seen in DFlox animals (indicated by 




The averaged breathing parameters during exposure to hypoxia for each group of 
mice are shown in Figures 2.7 and 2.8.  All groups of mice showed a similar initial 
hyperventilatory response for the first one minute after the onset of hypoxia (Figure 
2.7A), followed by a decline (“roll-off”) to a steady breathing rate in the second 
minute which remained relatively unchanged throughout the remaining period of the 
experiment. In both the DFlox and α2-KO mice the steady-state breathing rate was 
similar to the normal resting (baseline) respiratory frequency established in the 
earlier systematic characterization by Mahmoud, 2015a (269.3 ± 8.35 breaths per 
minute).  On the other hand the breathing frequency in the DKO mice continued to 
fall in the second minute after hypoxia, and then remained significantly slower in 
comparison to the other groups throughout the remaining part of experiment (Figure 
2.8A). The averaged breathing frequency of DKO animals over 3-6 minutes after 
hypoxia (i.e. the initial part of the steady-state response) was 204.7 ± 5.6 breaths per 
minute (n=5 animals), and this was significantly different from both the DFlox 
controls (252.3 ± 3.9 breaths per minute, n=4 animals) and the α2-KO animals 
(241.0 ± 7.6 breaths per minute, n=4 animals; P<0.05). This significant difference in 
breathing rate was also observed in the averaged parameters taken over the last 3 
minutes of the steady-state response (7-10 minutes after hypoxia), as shown in 
Figure 2.8B.  
As shown in Figure 2.7B, there was no significant change in the tidal volume of the 
three groups of mice during exposure to hypoxia, and the tidal volumes remained 
similar to the baseline volume of 0.35  ± 0.02 mL established by Mahmood (2015a).  
Thus the hypoxic hyperventilatory response was not accompanied by a significant 




The minute ventilation is a product of both the breathing frequency and the tidal 
volume. Thus as shown in Figure 2.7C, there was an increase in minute ventilation 
within the first one to two minutes upon the onset of hypoxia in each of the three 
mice groups. Similar to breathing frequency, the minute ventilation of both the 
DFlox and α2-KO mice returned to a value similar to the resting baseline value 
(Mahmood 2015a) within two minutes of the onset of hypoxia, and remained 
relatively stable at this level throughout the rest of the experiment. Minute 
ventilation in AMPK DKO mice did not decline to the baseline value (96.87 ± 5.06 
mL/min) as in the other groups but rather was further decreased throughout the 
remaining part of the experiment after the initial hyperventilation (see Figure 2.7C).  
In parallel with the reduced breathing frequency and minute volume in DKO mice 
during hypoxia, the number of apnoeas recorded per minute during the initial part of 
the steady-state period (3-6 minutes post hypoxia) was significantly higher in these 
animals with a value of 22.63 ± 10.18 apnoeas/min compared to 10.3 ± 6.36 
apnoeas/min the control DFlox mice and 7.2±4.55apnoeas/min in the α2-KO mice 
(P<0.05, Fig. 2.8). The median apnoea duration was also significantly longer in the 
DKO mice averaging at 1137.81 ± 405.51 sec, compared to that in DFlox mice 
(865.5 ± 191.51 msec) and α2-KO mice (813.7 ± 252.10 msec) (P<0.05,  Figure 
2.8). In the later stage of the steady-state response (7-10 minutes post-hypoxia), the 
number of apnoeas per minute in DKO animals remained higher and the median 
duration longer than in DFlox and α2-KO mice, but this difference was no longer 
significant (Figure 2.8).   
Thus, a significant hypoventilation (reduced breathing rate), reduced minute volume 
and a higher number and longer duration of apnoeas were observed in DKO animals, 




the earlier characterization of breathing parameters in these groups of animals by 
Mahmood (2015a), and confirm that the animals used in the present study showed 
the observed phenotype after AMPK deletion in DKO mice. The analysis of 
brainstem c-Fos expression in these animals (below) can therefore be related to the 
observed phenotype in each group.  
2.3.2  Activation of brainstem catecholaminergic neurons by hypoxia and the effects 
of AMPK deletion 
As detailed in the Methods, following the 10-minute exposure to hypoxia in the 
plethysmography chamber the animals were moved back to their home cages for 
ninety minutes, to allow for c-Fos expression in the areas of the brain activated by 
the hypoxic stimulus. Their brains were subsequently removed after transcardiac 
perfusion under terminal anaesthesia, and processed for double-
immunohistochemistry to visualize TH- and c-Fos immunoreactive neurones in the 
areas of the brainstem involved in the control of breathing. Differences in the 
activation (c-Fos immunoreactivity) of these neuronal groups following hypoxia in 
the different AMPK deficient mice were examined, to identify areas of the brainstem 
which may be involved in generating the abnormal hypoxic ventilatory response 
(hypoventilation and apnoeas) seen in the DKO animals. 
Localisation of TH+ve neuron groups in the brainstem 
Figure 2.9 shows representative examples of the well-known distribution of TH+ve 
neurons (red, indicated by arrows) located in the dorsal NTS region (A2 neuronal 
group; A) and ventral A1 and C1 neuronal groups (B, C) and the dorsal C2 neuronal 
group (D).  The neurons in the A1, C1 and C2 groups were clustered together in 




the region of interest for cell counting in each case. In the case of the A2 neurons in 
the NTS however (Figure 2.9 A), the NTS was divided into its sub-regions as 
indicated, using a brain atlas (Paxinos & Watson, 1998) to define the boundaries of 
the individual regions. This allowed changes in c-Fos immunoreactivity to be 
investigated in each sub-region of the NTS, rather than analyzing the NTS as a 
whole. 
Total numbers of TH+ve neurons in DFlox, DKO and α2-KO mice 
As mentioned in the Introduction, certain important disorders of breathing are caused 
by the loss of catecholaminergic neurons in the respiratory control centres in the 
brainstem, such as in Rett syndrome. To investigate the possibility that the apnoeas 
and hypoxia-induced hypoventilation observed in DKO animals were due to a loss of 
such neurons in these animals, the total numbers of TH+ve neurons in each of the 
above regions of the brainstem (A2, C2, A1 and C1 neuronal cell groups) were 
counted. The counts for the sub-regions of the NTS (A2 neurons) in each of the 
DFlox (controls), DKO and α2-KO
  
groups of animals are shown in Figure 2.10A, 
while the counts for the A1, C1 and C2 regions are shown in Figure 2.10B, C and D. 
In each of these regions of the brainstem, the total number of TH+ve cells were 
found to be not significantly different between the DFlox animals and the DKO 
animals, except for the SubP region of the NTS where the DKO animals showed a 
significantly higher number of TH+ve cells compared to the DFlox controls (Figure 
2.10A).  Interestingly in the α2-KO animals there was a significantly higher number 
of TH+ve cells in all regions of the NTS (SubP, medial, SolC, ventral and 
ventrolateral), as well as in the A1 region in the ventral medulla, compared to DFlox 




ventilatory response in DKO animals is due to a loss of central brainstem 
catecholaminergic neurons, as a consequence of the AMPK deletion in these cells. 
Activation of the NTS neurons after exposure to hypoxia 
Following exposure of the DFlox, DKO and α2-KO mice to hypoxia (8% O2; 
10mins), c-Fos immunoreactive neurons were found in each of the different 
subdivisions of the NTS, as shown in Figure 2.11Ai.  Co-localization of both the TH 
(red) and the c-Fos (green) immunoreactivities reveal the A2 neurons that were 
activated following hypoxia in each subdivision (Figure 2.11 Ai). In each 
subdivision of the NTS the total number of double-labelled cells (TH + cFos) and the 
number of cells labelled for cFos alone (non-catecholaminergic cells activated by 
hypoxia), were counted (Figure 2.11 B).  
As seen in the histograms shown in Figure 2.11B, the majority of cFos+ve neurons 
in each of the areas of interest were also TH+ve. This is in line with expectations 
from previous work and demonstrates the importance of catecholaminergic neurones 
in the control of respiration and the response to hypoxia (Erickson and Millhorn, 
1994; Teppema et al., 1997; Hirooka et al., 1997). 
In SubP subdivision (which lies adjacent to the area postrema, AP; Figure 2,13Ai), 
the DFlox mice which served as the control group contained 1.09 ± 0.36 Th+cFos 
double-labelled cells/100µm
2 
(n= 23 sections, from 4 mice). In DKO mice by 
contrast the number of TH+cFos neurones was significantly reduced, to 0.27 ± 0.11 
cells/100µm
2 
(n= 22 sections from 5 animals, P<0.05).  In the α2-KO group, the 
SubP region contained 1.30 ± 0.20 cells/100 µm
2 
TH+cFos neurones, which was not 




In the medial subdivision (SolM), there was no significant difference in the numbers 
of TH+cFos double-labelled neurones in DKO mice compared to the DFlox controls 
(2.54±0.31 vs. 2.67±0.04 cells /100µm
2
 respectively, n= 22 sections from 4 animals 
in the DFlox controls and 5 animals in the DKO group; Figure 2.11B). In contrast, 
the medial region in α2-KO
 
mice contained a significantly higher number of 
TH+cFos neurones (3.88±0.31/100µm
2
, n= 13 sections from 4 animals), compared to 
both the DFlox controls and the DKO animals (Figure 2.11B).  
In the SolC, ventral (SolV) and ventrolateral (SolVL) subregions of the NTS the 
number of TH+cFos neurones was significantly higher in DKO mice compared to 
DFlox controls (Figure 2.11B). Thus the SolC in DFlox mice contained 4.96 ± 0.54 
cells/100µm
2 
(n= 22 sections from 4 mice), while in DKO animals this was 
significantly increased to a value of 6.24±0.54 cells/100µm
2 
(n= 23 sections from 5 
animals).  In the SolV, the number of TH+cFos neurones in the DFlox mice was 
5.06±0.70 cells/100µm
2
 (n=22 sections from 4 animals), while that of the DKO 
stood at 6.93±0.65 cells/100µm
2
 (n=23 sections from 5 animals; P<0.05).  The 
SolVL, the number of TH+cFos neurones in the DFlox mice was 3.29±0.38 
cells/100µm
2
 (n=22 sections from 4 animals), while in the DKO mice this was 
increased to 5.32±0.60 cells/100µm2 (n=23 sections from 5 animals; P<0.05, Figure 
2.11B). In α2-KO animals, these regions of the NTS showed a further increase in 
TH+cFos double-labelled cells which was significantly higher than in both the 
DFlox controls and the DKO animals (Figure 2.11B). Thus the SolC in α2-KO mice 
contained 9.06±0.65 cells/100µm
2
 (n= 16 sections from 4 mice), while the SolV 
region contained 8.70 ± 0.68 cells/100µm
2
 (n= 13 sections), and the SolVL region 
contained 7.26±0.59 cells/100µm2 (n= 14 sections). These values were all 




Activation of C2 neurons after exposure to hypoxia 
The C2 adrenergic neurons are located in the rostral part of the NTS in the dorsal 
medulla (Figure 2.11Aii). As shown in Figure 2.11B, there was a significant 
reduction in double-labelled Th+cFos neurones in DKO animals (5.48 ± 0.40 
cells/100μm
2 
n= 38 sections from 5 animals) compared to DFlox controls (6.75 ± 
0.62 cells/100μm
2
, n= 29 sections from 4 animals; P<0.05).  By contrast, the 
numbers of double-labelled neurons in the
 
α2-KO mice were not significantly 
different from the DFlox controls (6.64 ± 0.42 cells/100μm
2
, n= 23 sections from 4 
animals; Figure 2.11B).  
Activation of A1 neurons after exposure to hypoxia 
The A1 noradrenergic neurons are constituents of the ventral respiratory network 
located in the caudal part of the ventrolateral medulla (Figure 2.11Aiii). As shown in 
Figure 2.11B, there was a significant reduction in double-labelled Th+cFos neurones 
in DKO animals (3.88 ± 0.23 cells/100μm
2
, n= 45 sections from 5 animals) 
compared to DFlox controls (4.66 ± 0.26 cells/100μm
2
, n= 47 sections from 4 
animals; P<0.05).  In contrast, in the α2-KO mice there was a significant increase in 
double-labelled cells, to 6.86 ± 0.25 cells/100μm
2
 , n= 45 sections from 4 animals; 
P<0.05; Figure 2.14B). 
Activation of C1 neurons after exposure to hypoxia 
The C1 neurons are a group of catecholaminergic cells that are located in the rostral 
portion of ventrolateral medulla (Figure 2.11Aiv). In this region, there was a 











in the DKO mice (n= 30 sections from 5 animals; P≤0.05; Figure 
2.11B). By contrast, the numbers of double-labelled C1 neurons in the α2-KO mice 
were not significantly different from the DFlox controls (5.38 ± 0.28 cells/100μm
2
, 
n= 23 sections from 4 animals; Figure 2.11B).    
 
2.4 Discussion 
The analysis of total number of catecholaminergic neurons in the A1, A2, C1 and C2 
areas of the brainstem (Figure 2.9) in the present study showed that there was no loss 
of TH+ve neurons  in the DKO animals when compared to the DFlox controls. 
Indeed in the SubP region of the NTS, a significant increase in the total number of 
TH+ve neurons was observed in DKO animals. Interestingly in A2KO animals, 
where only the alpha2 isoform of AMPK had been conditionally deleted, there was 
also a significant increase in the total TH+ve neurons in all parts of the NTS, and in 
the A1 ventral cell group.  
This is an interesting and important finding,  as it demonstrates that the hypoxia-
induced apnoeas and hypoventilation that are observed in the AMPK DKO mice, are 
not as a result of a loss of the brainstem catecholaminergic neurons as occurs, for 
example, in Rett syndrome. As discussed in Chapter 1 and in the Introduction, 
patients with Rett syndrome display life-threatening breathing arrhythmias with 
episodes of breath-holding and apnoeas, which may result in sudden death (Viemari 
et al., 2005; Stettner et al., 2007; Smith 2013). Studies using mouse models have 
shown that the underlying cause is the progressive loss of brainstem 
catecholaminergic neurons, as a consequence of a mutation in the MECP2 gene 




the present findings show that in DKO animals where AMPK has been conditionally 
deleted in catecholaminergic neurons, this does not lead to the death and overall loss 
of these neurons. Therefore the cause of the hypoxia-induced hypoventilation and 
apnoeas in DKO animals, is not due to an overall loss of TH+ve neurons in these 
animals. Instead it may be due to an alteration in the physiological function of the 
catecholaminergic neurons following AMPK deletion, rather than their death and 
overall loss. Thus for example in the absence of AMPK, it is possible that the ability 
of the catecholaminergic neurons to cope with metabolic stress (hypoxia) may be 
compromised, given the importance of AMPK in regulating the production of ATP 
(Chapter 1). Under these conditions, a compromised catecholaminergic modulation 
of the facilitatory drive to breathe in the brainstem respiratory networks, may result 
in the abnormal hypoxia response observed in the DKO animals. Essentially the 
hypoxic hypoventilation and apnoeas in DKO animals may be due to a compromised 
physiological response of brainstem catecholaminergic neurons as a result of the 
AMPK deletion, which is less severe than that seen in for example Rett syndrome, 
where these neurons are actually  lost completely.  
An interesting observation in the AMPK α2-KO animals, was a pronounced 
hyperplasia of the catecholaminergic neurons in all regions of the NTS and in the A1 
cell group, when compared to that in DKO and the DFlox groups (Figure 2.9). This 
is broadly in agreement with the known role of AMPK in regulating cell 
proliferation in a range of tissues, and suggests that knock-out of the AMPK α2 gene 
alone (but not both the α1 and α2 genes together), affects the development of the 
brainstem catecholaminergic neurons in these animals.  Activation of AMPK has 
been shown to suppress cell proliferation in tumor cells, with a sustained activation 




(Motoshima et al., 2006; Fisslthaler and Fleming, 2007). In cultured vascular smooth 
muscle cells AMPK α2 deletion has been shown to similarly lead to increased cell 
proliferation, and to accentuate neointimal hyperplasia in intact mouse after 
mechanical arterial injury (Song et al., 2011). While it is possible that the AMPK α2 
isoform has a specific effect on cell proliferation in brainstem catecholaminergic 
neurons in these mice, the mechanisms involved need to be further investigated. 
There is also a possibility that the hyperplasia observed in these neurons could be as 
a result of compensatory changes occurring within the neurons due to AMPK α2 
gene deletion or/and could also stem from novel expressions (e.g cytokines) from 
other brainstem non-catecholaminergic cells that surround the AMPK α2 deficient 
catecholaminergic neurons as a results of cell –cell communication as well as 
directly from the AMPKα2 deficient cells. Cytokines amidst other functions play a 
role in embryonic development, cellular proliferation and differentiation (Goldring 
and Goldring, 1991). Several regulatory cytokines such as the fibroblast growth 
factor, platelet-derived growth factor, epidermal growth factor and insulin-growth 
factor has been postulated to initiate the proliferation of fibroblast and  connective 
tissues cells, while the immunomodulatory ones e.g interleukin-1, tumor necrosis 
factor –alpha and interferon-gamma are involved in  modulating  growth response in 
nonimmune cells (Goldring and Goldring, 1991). Interestingly activation AMPK 
inhibits an array of interferon –gamma induced cytokines and chemokines in primary 
astrocytes and microglia an observation that points to a plausible involvement of 
cytokines in the brainstem catecholaminergic cells hyperplasia as a result of AMPK 
deletion (Meares et al., 2013).  
The analysis of c-Fos expression in the brainstem catecholaminergic groups (A1, C1, 




sites in the brainstem which may be involved in the abnormal hypoxic ventilatory 
response seen in DKO animals after AMPK deletion.   
Of particular interest are the A2 catecholaminergic neurons in the NTS, because the 
NTS is the primary central projection target for CSN afferents carrying 
chemoreceptor inputs from the peripheral carotid bodies, and is the major integration 
centre which transmits this information via output neurons to other brain regions 
(such as the ventral respiratory group neurons) that are involved in the control of 
breathing (Andresen and Medelowitz, 1996; King, et al., 2012; McGinnis et al., 
2013). In the NTS the A2 noradrenergic neurons have been reported to be 
preferentially sensitive to hypoxia (Buller et al., 2008; McGinnis et al., 2013), and 
are potent modulators of ventilation during hypoxia (Soliz et al., 2008; Buller et al., 
2008;  Li et al., 2008). The high sensitivity of the NTS to hypoxia is suggested for 
example in humans via clinical reports (McGinnis et al., 2013). Adults and children 
who died of hypoxia have been reported to have greater apoptotic index in the NTS, 
compared to that of the close-by dorsal motor nucleus of the vagus and the 
hypoglossal nucleus (McGinnis et al., 2013). Furthermore autopsy reports of adults 
who died of central sleep apnoea (a disease that is characterized by repetitive central 
apneas with hypoxia) reveal the presence of acute bilateral lesions at the level of the 
NTS (Parenti et al., 2005).  
In the present study of c-Fos expression in the A2 neurons in the NTS after exposure 
to hypoxia (Figure 2.10), most prominently there was a specific reduction in the 
activation in the SubP region of the NTS in the DKO animals, as compared to the 
DFlox controls. The SubP region of the NTS is in close approximation with and 
surrounding the highly vascularized area postrema (AP). Its blood supply is unusual 




which then break up into capillaries of normal size in the SubP before supplying the 
rest of the medulla (in a similar way to a portal system; Fodor et al., 2007; McGinnis 
et al., 2013). These short vessels convey re-entrant venous blood from the AP into 
SubP region after a prolonged stay in the AP, resulting in a relatively low O2 
saturation at the SubP capillary bed (Fodor et al., 2007; McGinnis et al., 2013). 
Therefore it is possible that during hypoxia there is a resultant potentiation of this 
effect, a phenomenon that may lead to an increased sensitivity and greater excitation 
of the A2 neurons in the SubP region. The SubP A2 neurons may therefore be in a 
particularly appropriate position to be activated by hypoxia, and by their output 
projections to drive the hypoxic ventilatory response. The reduced activation of these 
neurons in DKO animals (Figure 2.10) may be therefore an important factor in 
generating the apnoeas and hypoventilation seen in DKO animals during hypoxia. 
Interestingly, the significantly reduced activation of SubP catecholaminergic neurons 
was only seen in DKO animals, while the activation of these neurons in α2-KO 
animals was the same as in the DFlox control group (Figure 2.10B). This suggests 
either that the complete knock-out of both isoforms of AMPK in SubP neurons is 
necessary to obtain this effect, while the α2 isoform alone is not sufficient, or 
possibly that only the α1 isoform is expressed in SubP neurons, so that the α2-KO 
animals still have a normal AMPK function. Further characterization of AMPK 
expression in this area of the brainstem is necessary to investigate these possibilities.   
The C2 adrenergic neurons are reported to have a net excitatory effect on breathing 
and chemoreception (Li et al., 2008). Previous studies have shown that the C2 cells 
in the rostral NTS are activated during hypoxia in various experimental animals 
(Erickson and Millhorn, 1994; Teppema et al., 1997). In this work there was a 




to the Floxed , a finding that showed that the lack of AMPK decreased the activation 
of these neurons and thereby compromised their normal modulation and funneling of 
the chemoafferents signals to the ventrolateral medullary respiratory neurons ( 
including the A1 and C1 neurons ) that drives respiration during hypoxia. Apart from 
the direct effect of AMPK deletion, the decrease excitation observed in these cells 
may as well be due to a decrease in the facilitatory hypoxic response signals from the 
subP region. Therefore, in all the deficit in the activation of the C2 neurons in the 
DKO mice during hypoxia may be a prominent contributing factor to the observed 
phenotype (hypo ventilation and apnoeas) that was observed in these mice. 
In contrast to the marked reduction in activation of the SubP A2 neurons and C2 
neurons in the dorsal brainstem by hypoxia in DKO animals, in all of the other 
regions of the NTS there was either no change in the activation of catecholaminergic 
neurons compared to DFlox controls (medial region), or a significant increase 
compared to the DFlox controls (SolC, ventral and ventrolateral regions of the NTS; 
Figure 2.10B).  Furthermore, in all of these regions, it should be noted that in the α2-
KO animals this increase in activation after hypoxia was even greater than in the 
DKO animals (Figure 2.10B). These sub-regions of the NTS are known to be 
involved in the integration and transmission of chemoreceptor information from the 
carotid bodies (Andresen and Mendelowitz, 1996; Song et al., 2011; Bathina et al., 
2013; Mayer et al., 2015). Previous studies have shown that neuronal groups 
(including the catecholaminergic A2 cells) in these NTS sub regions are activated 
during hypoxia (Erickson and Millhorn, 1994; Teppema et al., 1997). In addition, the 
medial NTS is the first point for the termination of baroreceptor sensory signals 
entering the central nervous system, and thus these neurons are also importantly 




regions of the NTS, therefore, can be interpreted as a secondary consequence of the 
hypoventilatory response to hypoxia in DKO animals, due to the decreased 
activation of the SubP neurons, as discussed above.  Interestingly, the observation of 
the increased activation of these regions in the α2-KO animals, compared to the 
DKO group, suggests that the α2 isoform of AMPK may have a particular role to 
play in mediating this increased activation during hypoxia in these regions of the 
NTS.  
In the ventrolateral brainstem, the activity of the A1 noradrenergic neurons and the 
C1 adrenergic neurons is strongly modulated by efferent outputs from the NTS 
neurons (Figure 2.11A), and they form part of the ventral respiratory column which 
contains key interacting and excitatory respiratory neurons that generate the 
breathing rhythm motor pattern (Hirooka et al., 1997; Alheid et al., 2011; Smith et 
al., 2012). Thus, afferent input from the carotid bodies via the CSN is integrated in 
the NTS areas in the dorsal brainstem, after which it is transmitted to the 
downstream A1 and C1 neurons in the ventrolateral brainstem (Figure 2.12A). 
Therefore the observed changes in the activation of the ventrolateral A1 and C1 
neurons in the DKO mice as compared to the DFlox controls during hypoxia (Figure 
2.11B), are likely to be due to the changes in the transmission of the chemosensory 
signals from the NTS in the dorsal brainstem, as discussed above. The reduction in 
activation of the A1 neurons in DKO animals, may be related to the decreased 
transmission of efferent signals from the SubP and C2 regions, for example (Figure 
2.12B).  
The C1 adrenergic neurons, which showed an increased activation during hypoxia in 




functions such as the neuroendocrine responses to infection and inflammation, 
reproduction, glucose homeostasis, thermoregulation, hypothalamo-pituitary axis-
(HPA-) mediated stress responses, food consumption and breathing (Guyenet et al., 
2013). Although the physiological role of these neurons is complex, it is generally 
accepted that hypoxia results in their activation (Erickson and Millhorn, 1994; 
Hirooka, et al., 1997; Teppema et al., 1997; Greenberg et al., 1999; Guyenet et al., 
2013). Previous work has shown that hypoxia excites the C1 adrenergic neurons in 
the rostral ventrolateral medulla both through a projection from the caudal part of the 
NTS, and also secondarily by a direct (self–autonomous) or indirect activation (via 
the release of glial transmitters, e.g ATP) in response to central nervous system 
hypoxia, an effect that may contribute to the Cushing response (Reis et al., 1994; 
Guyenet et al., 2013). Therefore the increased activation of the C1 neurons in the 
DKO mice observed in this work may be as a result of the excitation of these cells 
via chemosensory inputs to the ventrolateral medulla from the commissural, ventral 
and ventrolateral NTS subnuclei that were significantly excited during hypoxia in 
these mice as compared to their DFloxed counterparts, as well be a self –autonomous 
excitation of a subset of these cells as result of brainstem hypoxia that might have 
occurred during the period in which the animals were exposed to the hypoxic 
challenge.  It is also possible that the increased excitation observed in the C1 neurons 
during hypoxia in the DKO mice may be as result of a subset of these neurons 
mediating other physiological function(s) such as sympathetic nervous system 






The analysis of TH and c-Fos expression in the brainstem of DKO mice in 
comparison with their DFlox controls in this Chapter, shows firstly that the hypoxia-
induced apnoeas and hypoventilation seen after AMPK deletion in DKO mice is not 
due to a loss of brainstem catecholaminergic neurons, as occurs for example in 
certain breathing disorders such as Rett syndrome. Instead, the deletion of AMPK 
appears to result in a markedly reduced activation of neurons in the SubP region of 
the NTS, and to a smaller extent also in the C2 region in the dorsal brainstem, during 
hypoxia. Since the NTS is known to be the primary site of termination of the carotid 
body afferent inputs to the brain, the decreased activation of the SubP region in 
particular shows for the first time that AMPK in specific NTS neurons is necessary 
for the effective integration and transmission of the chemoafferent signals from the 
carotid bodies. The reduced integration and onward transmission of the carotid body 
afferent inputs to the downstream ventrolateral medullary respiratory neurons, is 
suggested to be the underlying cause of the hypoventilation and apnoeas that are 
observed in DKO animals.  
This finding is potentially of clinical significance,  as it illustrates specific sites 
within the dorsal brainstem where disorders of AMPK expression or function could 
result in breathing disorders such as, for example, non- obstructive sleep apnoeas, 
and could also be involved in the physiological adaptation to living at altitude. 
Further studies of AMPK expression and function in the NTS neurons are necessary 
to investigate the potential for AMPK as a therapeutic target in the treatment or 
management of respiratory disorders of central brain origin. 
 
 Figure 2.1: Schematic diagram showing the use of the Cre–
recombinase technique to generate genetic knock-out of a target gene. 
Cross-breeding a Cre-expressing mouse with a mouse in which the 
target gene is flanked by two loxp sequences, results in offspring in 




Main (Animal) Chamber 
 Figure 2.2:  A, Schematic diagram of the Buxco small animal whole-body 
plethysmograph, showing the main animal chamber, the reference chamber 
and the pressure transducer monitoring changes in relative pressure between 
the two chambers (adapted from DeLorme and Moss, 2002). B, example 
recording of steady breathing of an animal in the main chamber, showing a 
decrease in recorded pressure during inspiration and conversely an increase in 
recorded pressure during expiration (see also Figures 2.3 – 2.6).  (Adapted from 




Figure 2.3.  Example plethysmograph recording from an AMPK Dflox 
control mouse in the initial part of the experimental protocol, in 
normoxia. The record begins (time=0, uppermost panel) a few minutes 
after the animal was first put into the plethysmograph chamber.  Each 
panel follows consecutively. Time on the X-axis is in milliseconds.  
Green vertical lines indicate the time of peak inspiration for each 
breath. Note the irregular breathing pattern and periods of high-
frequency pressure changes, associated with exploring, sniffing and 
grooming movements of the animal (arrows), which made it difficult to 
obtain steady-state baseline breathing records from naïve animals that 




Figure 2.4. Response of a representative AMPK Dflox control mouse 
to hypoxia. Plethysmograph recording from an AMPK Dflox control 
mouse over the first 3 minutes and 20seconds after the start of the 
exposure to hypoxia. Time=0 (uppermost panel) is immediately after 
the end of the pressure artefact caused by the switch to the hypoxia 
gas mixture. Note initial hyperventilation (uppermost two panels) 
followed by steady breathing at a lower rate, with occasional apnoeas 
(blue vertical lines, asterisks). Apnoeas followed gasps, but not all 









Figure 2.5. Response of a representative AMPK DKO mouse to hypoxia. 
Plethysmograph recording from a DKO animal over the first 3 minutes 
and 20seconds after the start of the exposure to hypoxia. Time=0 
(uppermost panel) is immediately after the end of the pressure artefact 
caused by the switch to the hypoxia gas mixture. Note initial 
hyperventilation (uppermost two panels) followed by steady breathing 
at a lower rate, with occasional apnoeas (blue vertical lines, asterisks). 
Apnoeas in DKO animals were more frequent and longer in duration, 








Figure 2.6. Response of a representative 2-KO mouse to hypoxia. 
Plethysmograph recording from a α2-KO mouse over the first 3 minutes 
and 20 seconds after the start of the exposure to hypoxia. Time=0 
(uppermost panel) is immediately after the end of the pressure artefact 
caused by the switch to the hypoxia gas mixture. Note initial 
hyperventilation (uppermost two panels) followed by steady breathing at 
a lower rate, with occasional apnoeas (blue vertical lines, asterisks). 
Apnoeas were similar in duration to those seen in DFlox controls. 
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Figure 2.7.  Hypoxic breathing parameters in AMPK Dflox, DKO and 2-KO  
animals. Plots show A, breathing frequency (breaths/minute), B, tidal 
volume (ml) and C, minute ventilation (ml/minute) averaged over each 
minute after the start of the exposure to hypoxia.  Open circles, AMPK 
Dflox animals (n=4); filled squares, AMPK DKO animals (n=5); open 
triangles, AMPK 2-KO animals (n=4). N, averaged baseline (resting) values 
obtained by Mahmoud (PhD thesis, 2015a) in control animals that had been 
habituated to the plethysmograph chamber.   
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Figure 2.8. Averages of breathing rate (left), number of apnoeas 
(middle) and apnoea duration (right) over 3-6 minutes (A), and 7-10 
minutes (B), of exposure to hypoxia in each group of animals and (c) 
averages of Minute Ventilation over 3-6 minutes (i) and 7-10 
minutes(ii) of hypoxia. Note that the DKO animals show a significant 
sustained hypoventilation over the 10 minutes of hypoxia, and 
significantly higher numbers of apnoeas, of longer duration, over the 
initial 3-6 minutes of hypoxia. Similarly the minute ventilation of the 
DKO mice show a significant reduction throughout the 3-10 minutes of 
hypoxia but interestingly the A2KO animals show a significant 
reduction in the initial 3-6 minutes  before returning to the normal 
baseline value in the 7-10minutes of hypoxia. 
(* =group significantly different from the controls , P< 0.05) 
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C. Averages of Minute Ventilation over 3-6 minutes (i) and 





Figure 2.9.  TH-immunoreactive (catecholaminergic) neuronal cell 
groups in the brainstem.  A, transverse section through the dorsal 
brainstem showing the nucleus tractus solitarius (NTS) of the left and 
right sides. Midline is at the centre of the image. CC, central canal; AP, 
area postrema. The regions of the NTS, defined by the presence of the 
TH+ve neurons (red, arrows) and with reference to the atlas of Paxinos 
and Watson (REF), are shown: SubP, medial, central, ventral and 
ventromedial (SolM, SolC, SolV and SolVL respectively). B, the A1 cell 
TH+ve cell group in the ventral medulla, lying above the lateral 
reticular  nucleus (LRt). C, the C2 TH+ve cell group in the dorsal 
medulla, lying rostral and dorsal to the NTS. D, the C1 cell group in the 
ventral medulla, lying just above the ventral surface of the brainstem.  
A. 
B. C. D. 
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Figure 2.10. Total numbers of TH-immunopositive (catecholaminergic) 
neurons in brainstem regions of AMPK Dflox, DKO and 2-KO animals. A, 
TH+ve neurons In each sub-region of the the nucleus tractus solitarius (NTS), 
shown in Figure 2.9. B, C and D, TH+ve neuron counts in the A1, C1 and C2 
regions of the brainstem (Figure 2.9). Note that there is no loss of 
catecholaminergic neurons in any of these areas in DKO animals, while in 
2-KO animals there is a significant increase in the number of TH+ve cells in 
the NTS and A1 regions. 
 (* =group significantly different from the controls , P< 0.05) 


























Figure 2.11 (previous page).  A, Representative examples of TH+ve (red),  c-Fos +ve 
(green) and double-labelled neurons in the NTS region (i), C2 region (ii), A1 region (iii) 
and C1 region (iv) of the brainstem.  Scale bars, 50 μm. B, Counts of TH+ve c-Fos+ve 
double-labelled cells, and c-Fos only cells, in each region of interest (as shown in 
Figure 2.9), normalised to cells/100m2 in relation to area of the region of interest.   
Open bars, AMPK Dflox (control) animals; filled bars, AMPK DKO animals; hatched 
bars, 2-KO animals. (* =group significantly different from the controls , P< 0.05) 


















Figure 2.12. Summary diagram showing the hypothesised effects of AMPK 
deletion on the hypoxic ventilatory response.  A, in normal animals, hypoxia 
activates the carotid body afferents in the carotid sinus nerve (CSN), which 
project to the caudal NTS neurons in the dorsal brainstem. The CSN afferent 
input is integrated with a hypothesised local hypoxia signal in the NTS. The NTS 
neurons stimulate hypoxic hyperventilation through their strong modulation of 
the ventral respiratory group (VRG) neurons.  B, by contrast in DKO animals, 
deletion of AMPK in catecholaminergic neurons in the NTS (gray) results in 
hypoxic hypoventilation and apnoeas, even though the CSN afferent input is 
normal, indicating that AMPK is required for the correct integration of the local 
hypoxia signal in the NTS, and for the normal modulation of the VRG neurons. 





The effects of AMPK deletion on the peripheral carotid body 
 
3.1 Introduction 
A definitive index of the carotid body response to hypoxia is its chemosensory signal 
that serves as the final common output to the central nervous system (Kumar, 2007).  
Previous classical electrophysiological studies have shown that the carotid body arterial 
PO2 – response curve is sigmoid in nature with the chemosensory discharge starting to 
rise gradually at about 400-140mmHg arterial PO2  up to  approx.100mmHg by which 
time the slope increases and then rises sharply at about 70-75mmHg arterial PO2  before   
attaining its maximum activity at approx. 20-30mmHg (Kumar, 2007).  
Interestingly physiological recordings in vitro from isolated carotid bodies from both 
DKO and DFlox mice showed  similar patterns as described above (see Fig 3.2 ; 
Mahmoud  et al. 2015b),  an observation that confirms that the CSN afferent responses 
to hypoxia are normal in both groups of animals. 
The chemosensory synaptic transmission at the level of the carotid body during hypoxia   
involves the interplay of both excitatory and inhibitory neurotransmitters and 
neuromodulators as earlier discussed in chapter 1. Key examples of these transmitters 
are catecholamines (e.g dopamine and norepinephrine), acetylcholine, ATP and 5-
Hydroxytryptamine (Nurse, 2005; Lahiri et al., 2006).  
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 In the DKO mice the AMPKα1 and α2 isoforms were deleted from all TH-expressing 
(catecholaminergic) cells, including the glomus cells in the carotid body and it is 
unknown whether there is a loss of TH+ve (catecholaminergic) cells in the peripheral 
carotid body of DKO animals, as a result of the deletion of the AMPK gene even though 
their CSN in vitro physiological recordings are normal. 
 Therefore in this section of my work, I carried out experiments to examine the 
morphology of the carotid bodies in the AMPK DKO mice and compared it to the 
carotid bodies of DFlox mice with the aim of determining whether the deletion of 
AMPK had any effect on the total numbers of TH+ve (catecholaminergic) cells present 
in the carotid body of these mice.   
Accordingly in this part of my work I examined the numbers of TH+ve cells in carotid 
bodies taken from DKO and DFlox animals.  
        
3.2 Materials and Methods  
A total of 3 AMPK DKO mice and 4 AMPK DFlox mice were used in this study. The 
animals were kindly provided by Prof. Mark Evans. Dr Oluseye Ogunbayo was 
responsible for the management of the breeding programme and the genotyping of the 
animals, as described in Chapter 2. All experiments were carried out in concordance 
with the Home Office legislation. 
Under terminal anaesthesia (0.2 ml pentobarbital, i.p.), the thorax was opened and the 
heart and ascending aorta were visualized under a dissecting microscope. The aortic 
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arch and the common carotid artery up to and including the carotid bifurcation, were 
gently cleared and excised. The dissection procedure was carried out by Dr. Jorge 
Navarro Dorado (Centre for Integrative Physiology, University of Edinburgh). Unlike in 
the rat and other animals (De Caro et al 2013), in the mouse the carotid bodies are not 
gathered together in a single identifiable mass, but instead are found in relatively small 
diffuse clusters attached to the bifurcation of the internal carotid arteries. A particular 
challenge in these experiments was to dissect out and identify the carotid bodies in the 
mice, as described below.  In order to keep the internal carotid arteries stretched out, so 
that the anatomy could be recognised subsequently, the aorta and carotid arteries were 
suspended with a small weight in a vial of 4% paraformaldehyde in 0.01M PBS for 1h at 
4oC.  The tissue blocks were then washed three times (15 minutes each) in 0.01M PBS, 
and transferred to 20% sucrose in 0.01M PBS plus 0.01%NaN3 until needed.  Prior to 
immunohistochemistry the carotid artery blocks were cut using a Cryostat (Bright 5040 
microtome, Cryostat Instrument Company Ltd, Huntingdon, UK). The sections were 
collected and placed directly onto poly-l-lysine pre-coated slides (Superfrost®plus, 
Thermoscientific, UK).  Thereafter the slides were incubated in 37oC for 2hrs, and 
stored for immunolabelling at -80oC. 
 The carotid body sections were stained for TH-immunoreactivity using the same 
methods as described in Chapter 2.   Images of the carotid body sections were acquired 
using a Leica digital camera, controlled by Leica acquisition software (AIS) attached to 
an upright Leica microscope (LEICA DMR).  Images were captured with both x10 and 
x20 objectives.  The x20 images were used for the counting of the TH-immunopositive 
cells.   
78 
 
TH-immunoreactivity was visualized using the Alex Fluor 568 secondary antibody (Life 
Technologies Ltd, UK), using the red channel of the imaging system, in the same way as 
for the brainstem sections in Chapter 2.  In addition, the auto-fluorescence of the arterial 
wall epithelial cells was visualized using the green channel (see Figure 3.1).  Each 
section was searched for a recognizable length of the carotid arteries, and specifically 
for a section through the bifurcation of the internal carotid arteries.    Clusters of TH+ve 
cells were searched for in the region of the bifurcation where it was found, 
corresponding to the carotid bodies.  The larger mass of the superior cervical ganglion 
(SCG) was also strongly TH+ve, and this was usually recognizable as a large structure 
separate from the arterial walls (see for example Figure 3.1). 
Regions of interest were drawn around clusters of TH- positive cells in each section of 
the carotid body where it was found, and the counts from each region of interest per 





3.3.1 Catecholaminergic cells in the carotid body  
Unfortunately after sectioning of the fixed dissected tissue, the carotid body bifurcation 
could only be clearly identified in 3 of the 4 DFlox mice preparations, and 2 of the 3 
DKO mice preparations.  In the remaining preparations it was not possible to 
confidently identify any groups of TH+ve cells as a cluster that could represent the 
carotid body, and so these were excluded from analysis.  
In each of the identified carotid bodies of the DKO and DFlox carotid bodies there was a 
robust presence of TH+ve cells, as illustrated for one DKO animal in Figure 3.1.  Cell 
counts of TH+ve cells in each group are shown in Table 3-1. From the cell counts it is 
apparent that the mean number of TH+ve cells in the carotid bodies from DKO animals 
is reduced, compared to that in the DFlox controls.  
Table 3.1:  Total number of TH+ve cells in the carotid bodies of DFlox and DKO animals 
        N TH+ve cells/ 100μ2 
DFlox  7 sections, from 3 animals 131.51 ± 16.14 
DKO  4 sections, from 2 animals 60.16 ± 15.28 
 
However, the small number of preparations available (with the DKO results coming 
from only two animals), means that it is difficult to reliably draw a conclusion from a 
statistical comparison of the DKO animals with controls.  Although the mean numbers 
of TH+ve carotid body cells in the two DKO animals is  clearly lower than the mean 
count in DFlox animals (Table 3-1), more data from additional DKO animals is required 
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before it can be  concluded whether or not there is a significant decrease in TH+ve cells 
in the carotid bodies of DKO animals.  
 
3.4 Discussion 
The small number of animals involved in this part of the work, and the limited number 
of sections in which the carotid bifurcation and the carotid bodies could be identified 
with confidence, means that a clear conclusion to the question of whether there is a 
change in the number of TH+ve cells in the carotid bodies of DKO animals or not, 
cannot be drawn from the present study.  The likely reason for the difficulty in 
recognizing the carotid bodies in some of the sections is the twisting and deformation of 
the dissected tissue blocks during the fixing procedure, so that it was difficult to identify 
the carotid bifurcation. Further experiments to improve the fixation step to hold the 
tissue in a standard orientation, to avoid this from happening, are necessary. 
Unfortunately because of time constraints, and because of the fixed number of animals 
available from the mouse colony breeding programme for this part of the study, it was 
not possible to try alternative ways of fixing the tissue blocks.   
The finding of significant numbers of TH+ve cells in the carotid bodies of both of the 
DKO mice included in this study, however, suggests that the morphology of the carotid 
bodies in DKO mice might not have been affected by the deletion of AMPK in the 
glomus cells.  However if further work confirms the observed reduction in the number 
of TH+ve cells in the carotid bodies of the DKO animals, this will raise interesting 
questions relating to how the deletion of AMPK causes the loss of these cells in the 
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carotid bodies. In addition, although the role of TH neurotransmission in the sensing and 
transduction of hypoxia in the carotid body is not entirely clear (as discussed in Chapter 
1), the in vitro results from isolated carotid body-CSN preparations (Mahmoud et al 
2015b) show that the afferent firing  evoked by hypoxia is not different from normal. 
Therefore, if further experiments confirm the a loss of TH+ve cells in the peripheral 
carotid bodies after AMPK deletion, as indicated by the present results, the mechanisms 
by which the normal afferent response to hypoxia is maintained, will need to be 
investigated. In addition it will be interesting to determine how the deletion of AMPK in 
the peripheral carotid bodies leads to a loss of TH+ve cells, while by contrast in the 
brain (Chapter 2), AMPK deletion leads to a hyperplasia of TH+ve neurons in the dorsal 
brainstem. Further work is therefore necessary to obtain more definitive results, 
regarding the effects AMPK deletion on the TH+ve cells in the peripheral carotid bodies 
of the DKO animals. 
 The possibility of a 2-fold reduction in the number of catecholaminergic (TH-
expressing) cells in the carotid body of the AMPK DKO mice as opposed to the DFlox 
animals (although more work is needed) appears to be obvious probably due to the 
action of nitric oxide (NO). Nitric oxide is one of the neurotransmitters that are 
expressed by the glomus cells of the carotid body (Kumar, 2007). It is synthesised by 
the enzyme nitric oxide synthase (NOS) which exists in three isoforms; neuronal 
(nNOS), endothelial (eNOS) and inducible (iNOS) (Lira et al. 2007). nNOS and eNOS 
produce nitric oxide at lower concentrations and at such levels it plays a role in 
promoting cell growth and survival in many tissues but conversely iNOS produces nitric 
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oxide at higher levels leading to cellular damage including DNA damage and inhibition 
of oxidative metabolism (Lira et al., 2007; Meares et al., 2011). 
Interestingly AMPK activation causes the inhibition of iNOS expression in many cell 
types including myocytes, adipocytes and macrophages while it phosphorylates and 
activates nNOS and eNOS isoforms (Pilon et al., 2004; Lira et al., 2007) (see Figure 
3.3). 
Thus the deletion of AMPK in the DKO mice may lead to an increase in the expression 
of iNOS in the carotid body with a resultant production of high levels of nitric oxide 
leading to the damage of the catecholaminergic cells in these animals. 
On the other hand it is worth noting that nitric oxide has a facilitatory influence on the 
actions of AMPK either via the inhibition of AMPK phosphatases or activation of 
AMPK kinases (Lira et al., 2007) (see Figure 3.3). 
 Intriguingly if there is a loss of catecholaminergic cells in the carotid body of the DKO 
mice coupled with the demonstration that the discharge from the CSN is normal in these 
animals during hypoxia (see Mahmoud et al. 2015b)  then it is plausible that there is a   
certain degree of  redundancy  in the  physiology of  the carotid body with regards to 
response to hypoxia i.e. it  may not be necessary for all the glomus cells to be activated 
before a full discharge is recorded in the CSN during hypoxia alternatively there is a 
possibility that the cells that might have been loss following AMPK deletion are a subset 
of the glomus cells which may not be  involved in mediating the hypoxic chemosensory 
process in the carotid body. Kumar and Prabhakar (2012), have reported attempts to 
classify glomus cells into types A and B with the type A cells being the presynaptic 
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elements that transmit hypoxic signals into the afferent nerve (CSN) while the type B 
cells are non-innervated glomus cells which may not be involved in the response to 
hypoxia.  Taken together if these results are confirm it shows that although AMPK 
deletion may cause a reduction in the total glomus cell counts it has no effect on the 

























             
                         
Figure 3.1: .(a)  Tyrosine Hydroxylase (TH) immunostaining (red) of carotid body (CB) 
and superior cervical ganglion (SCG) in a  DKO  animal.  Autofluorescence (green) of 
the arterial wall of the internal carotid artery indicates the location of the CB 
adjacent to the carotid bifurcation. Scale bar, 100μm. (b), higher magnification view 
of the rectangular area indicated in (a), showing clusters of TH+ve cells (in circles, 
were cells were counted). Arrows indicate TH-ve cells within the carotid body. Scale 
bars, 25μm. (c) and (d), show TH immunofluorescence staining of the glomus cells of 
the carotid body in a DFlox mice. Circles indicate clusters of TH+ve cells in areas 
where cells were counted. Arrows indicate TH-ve cells within the carotid body. Scale 
bars are 25μm(c,d). Abbreviations: CCA, Common carotid artery; ICA, Internal carotid 
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Figure 3.2: (A&B) Show extracellular recordings of single fibre chemosensory 
firing versus PO2 for DFLOX and DKO mice respectively. Inset, shows single fibre 
discrimination. The middle panel (c) shows the frequency- time histogram for 
fibre chemoafferent discharge for DFLOX mice (i) and DKO animals (ii). (D) 
Sigmoid graphs showing the PO2 – response curves of the glomus cells in (i) 
DFLOX mice and (ii) DKO animals. Observe (lower panel) the exponential rise in 
chemoafferent discharge frequency following reductions in superfusate PO2 in 
both the DKO and DFLOX carotid bodies with a peak frequency at a PO2 of 
approx. 74mmHg and measuring at 12.5 ±1.6 Hz for the control mice and 
13.9±1.5Hz for the DKO group.  (n=10 for DFlox; n=8 for DKO, P≤0.001). 









        









Figure 3.3: A proposed schematic diagram showing the interaction 
between AMPK and NO (e.g in skeletal muscles).Θ= Inhibition;      = 
activation;       = AMPK activation. nNOS= neuronal nitric oxide 
synthase; eNOS= endothelial nitric oxide synthase; iNOS= Inducible  
nitric oxide synthase;    NO =  increased levels of nitric oxide (Adapted 




Pilot Study to develop virus-induced targeted AMPK knock-out in brain areas 
 
 4.1 Introduction 
Previous work in this thesis has shown altered respiratory responses to hypoxia in 
AMPK DKO mice when compared to control DFlox animals. As shown in Chapter 
2, these mice also presented systematic changes in the activation of brainstem 
catecholaminergic neuronal groups that are known to be involved in the control of 
respiration, suggesting that AMPK has an important role to play in these brainstem 
areas in the normal hypoxic hyperventilatory response. In the absence of AMPK in 
these brainstem areas, the animals show the observed respiratory abnormalities. 
However, the above work was carried out in animals where the AMPK gene had 
been globally knocked-out in catecholaminergic cells (using a Cre-lox system under 
the control of a TH-promoter).  
 For further and more specific investigation of the neuronal mechanisms involved in 
the respiratory abnormalities following AMPK deletion, it would be beneficial to 
develop methodology to selectively delete AMPK in the brain only (i.e. Leaving 
other catecholaminergic cells, such as the glomus cells in the carotid body, 
unaffected). In addition, attempts could be made to target specific brainstem areas, to 
localise the effects of AMPK deletion in the different brainstem nuclei involved in 
the control of respiration. 
Therefore, this pilot study was designed to elucidate, whether a localised (targeted) 
knock-out of the genes carrying the α1 and α2 isoforms of the α-catalytic subunit of 
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AMPK in the brainstem of AMPK DFlox mice, would reproduce the same abnormal 
ventilatory responses as observed in the AMPK DKO mice.  
The recombinant viral vector technology, using adeno-associated virus (AAV), 
which allows for the targeting of localised populations of neurons or other cell types 
within a specific part of the nervous system (Kootstra and Verma, 2003; Zincarelli et 
al., 2008; Schultz and Chamberlain, 2008; Lentz et al., 2012; Aschauer et al., 2013; 
Holehonnur et al., 2014), was used for this work.  
 
 4.1.1 Recombinant viral vector technology 
 Background 
 The roles of various molecules in the development and function of the nervous 
system can be studied by using mice carrying conventional null mutations of the 
genes for these molecules (Ahmed et al., 2004). This conventional transgenic animal 
technology alters the genetic makeup of the cells or the tissue types and so the 
expression of the molecules concerned (Gordon et al., 1980; Palmiter and Brinster, 
1986; Gu et al., 1994; Glueck and Dzau, 2002; Haruyama, 2009; Miao, 2013; 
Holehonnur et al., 2014).  
Research using transgenic animal technology started in 1974, following the work of 
Janeisch and Mintz (1974), who generated transgenic animals by microinjection of 
viral DNA into blastocysts (Miao, 2013). This was followed by the generation of the 
first transgenic mouse by Gordon et al. (1980) through the pronuclear injection of a 
foreign gene into the mouse oocytes (Haruyama, 2009; Miao, 2013). One of the 
major approaches in generating conventional knockout animals is the Cre –loxP 
recombinase technique, which involves the use of Cre-recombinase to remove loxP- 
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flanked segments of DNA (Sauder and Henderson, 1988; Gu et al., 1994; Tsien et 
al., 1996; Ahmed, et al., 2004). This technique has been previously discussed in 
detail in Chapter 2.  
While in the conventional Cre-lox system the knock-out animals are generated 
through the breeding of Cre-expressing mice with mice in which the gene of interest 
has been flanked by loxP sequences, recent progress in genetic engineering and 
neuroscience has made it possible to deliver Cre–recombinase directly to specific 
groups of neurons in adult animals in vivo, using viral vectors such as adeno-
associated virus, lentivirus, herpes virus and adenovirus carrying the Cre sequence 
with resultant recombination (Stec, et al., 1999; Brooks et al., 2002; Kaspar et al., 
2002; Ahmed et al., 2004; Sinnayah et al., 2004; Holehonnur et al, 2014). This 
technique is referred to as the recombinant viral vector technology. 
 Recombinant viral vector technology      
Recombinant viral technology allows for the targeting of discrete populations of 
neurons or other cell types within specific regions of the brain, using recombinant 
viruses ( McCown et al., 1996; Kasparov and Paton, 2000 ; Sinnayah et al., 2002; 
Sinnayah et al., 2004; Holehonnur et al., 2014). These viruses are genetically 
engineered to carry transgenes of interest (for example, Cre- recombinase) and when 
injected into desired regions of the central nervous system, mediate the delivery and 
stable transduction of these genes into the cells of the region (Blomer et al., 1997; 
Naldini, 1998; Zufferey et al., 1998; Ahmed et al., 2004; Sinnayah et al., 2004; Lentz 
et al., 2012; Daya and Berns , 2008; Holehonnur et al., 2014). One of the advantages 
of this technology over the conventional transgenic animal technology is that it 
permits genes to be manipulated at virtually any point in the animal’s life span 
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relatively quickly and easily (Pitkow et al., 2001; Ahmed, et al, 2004; Sinnayah et 
al., 2004; Lentz et al., 2012; Holehonnur et al, 2014). Also, unlike the conventional 
knock out animals, mice exposed to this technique do not suffer from such 
limitations as embryonic or perinatal lethality and the compensatory regulation of 
other genes, which may result in altered observed abnormalities (Ahmed et al, 2004). 
Another advantage of the recombinant viral vectors is that they allow for selective 
delivery of Cre-recombinase to specific brain targets in which specific promoters 
have not yet been identified, as opposed to the conventional genetic knock–out 
technique that requires highly specific promoters for selective gene deletion and 
where these are not available, the technique is limited (Kilby et al., 1993; Stec, et al., 
1999; Brooks, et al., 2000; Kaspar et al., 2002; Sinnayah et al., 2004). A further 
consideration in the use of conventional transgenic animal technology is also in 
relation to the breeding and maintenance of mouse lines, but this shortcoming is 
greatly reduced in the recombinant vector approach since it only requires the 
generation and breeding of the Floxed mouse line. 
Although several recombinant viral vectors have been used for selective delivery of 
transgenes into mice in vivo (Connolly, 2002; Sinnayah et al., 2004; Ahmed, et al., 
2004; Holehonnur et al., 2014), the two most widely used viral vectors are the 
adeno-associated virus (AAV) and lentivirus (LV) ( Flotte et al., 1993; Peel et al., 
1997; Connolly, 2002; Wright et al., 2003; Ahmed, et al, 2004; Vasileva and 
Jessberger,2005; Daya and Berns, 2008; Holehonnur et al., 2014). These viruses 
have the ability to deliver and transduce genes into both dividing and non-dividing 





Adeno-associated virus vector 
Adeno- associated virus (AAV) vectors occupy a preeminent position in 
neuroscience research, in terms of gene delivery to adult mice brains and also have 
potential as a vector for human gene therapy for several genetic disorders like 
haemophilia, cystic fibrosis and muscular dystrophies (Vasileva and Jessberger, 
2005; Ahmed, et al, 2004; Broekman et al.,2006; Honaramooz et al., 2008; Daya and 
Berns, 2008; Schultz and Chamberlain, 2008; Zincarelli et al., 2008; Aschauer et al., 
2013 Chakrabarty et al., 2013 ; Holehonnur et al., 2014). 
AAV mediated gene delivery has been shown to be a safe and efficient method for 
extensive transduction of neurons and long-term expression of transgenes in the 
brain. The unique characteristics of AVV of not being toxic in vivo, lack of 
pathogenic ability, non- inducement of significant inflammatory and immune 
responses and the ease of its production within the laboratory at required titres, make 
it an ideal virus for in vivo use (Wright et al., 2003; Broekman et al., 2006; Daya and 
Berns, 2008; Zincarelli et al., 2008; Holehonnur et al., 2014).  
Lentiviral vectors are equally useful in gene delivery to cells as AAV (Connoly, 
2002; Ikawa et al., 2003). Lentivirus has the ability to integrate into non–dividing 
cells, such as neurons and provides stable and long–term gene expression in vivo. 
However one of the major advantages of the recombinant AAV vectors over the 
lentivirus is that they present low risk of insertional mutagenesis, due to their low 
integrating property with the host cell genome (Connolly, 2002; Ikawa et al.,2003 ; 
Daya and Berns.2008:;Schultz and Chamberlain, 2008; Chandrashekran et al., 2014).  
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In this pilot study, a commercially available adeno-associated virus vector, AAV-DJ 
(Vector Biolabs, Phiadelphia.USA) was used. This vector expresses an improved Cre 
transgene (iCre) under the influence of a cytomegalovirus (CMV) promoter, together 
with an enhanced green fluorescent protein (eGFP) as a reporter. The vector was 
used based on the fact that the technology and expertise for its effective injection 
into desired brain regions was available in Prof. Matthew Nolan’s laboratory, Centre 
of integrative Physiology, University of Edinburgh. The virus vector was injected 
into the brainstem of AMPK DFlox mice, in order to induce the knock-out of AMPK 
1 and 2 genes in the virally infected neurons. 
 The success of the deletion of the AMPKα1 and /or α2 cataytic subunits in the 
brainstem catecloaminergic neurons was confirmed by culturing AMPK DFlox 
mouse brain tissues with the AAV vector after which real-time quantitative PCR 
(qPCR) was carried out following the protocol as discussed in chapter 2 (all 
procedures were carried out by members of the Evans laboratory, Centre for 
Integrative Physiology, University of Edinburgh).  
  
4.2 Materials and Methods 
Animals 
A total of 6 AMPK DFlox mice (5 males and 1 females), weighing between 20-29g 
(9-10 weeks old), were used for this pilot study. All mice (a gift from Prof. Mark 
Evans, with the mice colony under the management of Dr.Oluseye Ogunbayo) were 
bred and housed in the BRR animal facility, Centre for Integrative Physiology, 
School of Biomedical Sciences. All procedures were carried out in accordance with 
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the University of Edinburgh guidelines for animal research in conformity with the 
UK Animals (Scientific procedures) Act 1986. 
 
 Surgery / Stereotaxic Injections  
All surgeries were performed by Dr Marlies Oostland (Centre for Integrative 
Physiology, University of Edinburgh). The mice were anaesthetised with isofluorane 
(Abbot Laboratories ltd, Berkshire, UK), placed in a stereotaxic frame, and local 
anaesthetic (Vetergesic, 0.03 ml of 0.03mg/ml buprenorphine per animal) was 
injected subcutaneously at the incision sites. The skin was swabbed with Betadine 
antiseptic solution (povidone-iodine 10%, Ecolab, Leeds, UK).  
The foramen magnum was exposed by gently pulling aside the muscles and 
overlying fascia. The dura between the foramen magnum and first cervical vertebra 
(C1) was opened with a small bent needle. Injections were made through this 
opening using glass pipettes which were slowly lowered into the brainstem using a 
micromanipulator attached to the stereotaxic frame. In terms of anatomical guidance 
for the injection sites, coordinates in relation to bregma or lambda were not used, but 
the midline and distance from the base of the skull were used, since injection were 
performed through the foramen magnum. 
The virus was injected using pulled glass pipettes with a tip diameter of 6-10μm. 
50nl of the virus was injected per injection site, totalling 800nl for 8 injection sites 
on each side of the brainstem. The virus titre used was 1.0x10
13
 GC/ml, based on the 
titres which were used routinely by Dr. Marlies Oostland for injection into the 
inferior olive and related structures (Oostland, unpublished, personal 




The dorsal brainstem was targeted by lowering the pipettes into the foramen 
magnum at an angle of 30-35
o
 to the vertical. A series of injections were carried out 
with the first injection at a depth of 3.5 mm, before being slowly raised to the next 
injection sites at 3.0, 2.5, 2.0,1.5.1.0, 0.5 and 0.2mm depth. The pipette was left in 
place in each position for 3mins.  At the last site the pipette was left in place for 5 
mins following the injection before being fully retracted very slowly. Bilateral 
injections were made at 0.1 mm lateral on each side of the midline. 
 
Ventral injections 
 The ventral areas of the brainstem were targeted by lowering the pipettes into the 
foramen magnum at an angle of 45-50
o
 to the vertical.  A series of injections were 
carried out as described above. Bilateral injections were made at 10 and 13 mm 
lateral to the midline, on each side. 
 The surgeries typically lasted for 2-2.5 hours. Mice were closely monitored for a full 
recovery after anaesthesia and returned to their home cage when fully awake. They 
remained in their home cage for two weeks before the next experiments were carried 
out. 
Plethysmorgraphy/ Immunohistochemistry 
Respiratory responses to hypoxia in the virus injected mice were recorded by using 
an unrestrained whole- body plethysmography as earlier described (Chapter 2). 
Three recording sessions were carried out for each mouse at 2 weeks, 3 weeks and 
3.5 weeks after the surgery.  At the end of the third plethysmographic run the 
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animals were deeply anaesthetised and transcardially perfused, and the brain was 
removed and processed for immunohistochemistry, as described in Methods, Chapter 
2.  Images of the brainstem sections were then acquired using a Leica digital camera 
as earlier described. The x20 images were used for the counting of the 
immunopositive cells. 
Virus infected cells were identified as those expressing GFP, while TH+ve neurons 
were visualised using the red channel of the imaging microscope as before. TH+ve 
neurons, and double-labelled neurons, were counted in the brainstem areas of interest 
(the NTS subdivisions, C2, A1 and C1 regions) using image J software (Fiji; an open 
source platform for biological–image analysis). The percentage viral transfection for 
each nucleus was then calculated, as the percentage of total TH+ve cells that were 





Hypoxia responses in virus-vector injected mice 
Fig. 4.1 shows the measured ventilatory response (left column) and the number of 
apnoeas per minute (right column) in each of the animals in this study, during the 5 
minutes of exposure to hypoxia (8% O2, 0.05% CO2, balanced with N2).  In the first 
experimental run 2 weeks after surgery three of the animals (mice 834, 840 and 844) 
showed a higher incidence of hypoxia-induced apnoeas (Fig. 4.1, upper panel). This 
is suggestive of the apnoeas observed in DKO mice during hypoxia (Chapter 2, 
Results, Figure 2.8). However the ventilatory response in these three virus-injected 
animals appears to be normal and no different from that seen in the other animals in 
the group. In subsequent runs (weeks 3 and 3.5 after surgery) these three animals no 
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longer showed the increased incidence of apnoeas (Fig. 4.1, middle and lower panel).  
Thus the apnoeas observed in the first exposure to hypoxia at 2 weeks post-surgery 
were not sustained. The ventilatory response to hypoxia in all of the animals also 
appeared to be normal, and none of the animals showed an evidence of hypoxia-
induced hypoventilation similar to that seen in DKO animals (Chapter 2). 
 
Transfection of brainstem neurons by Cre –virus vector injection  
Injection of the Cre-recombinase viral vector into both the dorsal and ventral 
portions of the brainstem resulted in varying degree of transfection of brainstem 
catecholaminergic neuronal populations after 3.5 weeks (Figures 4.2 – 4.7).  
Mouse 844: This mouse received dorsal and ventral injections of the Cre- 
recombinase viral vector.  There was a 43% transfection of the TH+ve A2 neurons in 
the SubP subdivision of the NTS, and 70% transfection of these neurons in the 
medial subdivision of the NTS, while that of the SolC, ventral and ventrolateral 
portions of the NTS were 61%, 76% and 85% respectively. There was no 
transfection of the C2 adrenergic neurons. Ventrally, there was a poor transfection of 
A1 neurons (9%) and 95 % transfection of the C1 adrenergic neurons (Figure 4.2).  
Interestingly this mouse showed a higher number of apnoeas in the first exposure to 
hypoxia (Figure 4.1), but this was not maintained and the respiratory responses to 
subsequent exposures to hypoxia were no different from normal animals (Figure 
4.1). 
Mouse 836: This mouse received dorsal and ventral injections of the Cre- 
recombinase viral vector.  After a period of 3.5 weeks, there was only a 33% 
transfection in the A2 neurons of the ventral subdivision of the NTS; 32% in the 
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ventrolateral subdivision; 19% in the SolC subdivision; 4% in the medial subdivision 
and 0% in the SubP subdivision. There was also no infection in the C2 neurons. On 
the other hand, 56% transfection of the A1 noradrenergic neurons was observed 
(Figure 4.3). 
Mouse 834: Injection of the Cre-recombinase viral vector into the dorsal brainstem 
of this mouse showed widespread transfection of the A2 neurons in many 
subdivisions of the NTS after 3.5 weeks:  96% transfection was seen in the 
ventrolateral subdivision; 97% in the ventral subdivision; 96% in the SolC 
subdivision; 94% in the medial subdivision and 35% in the SubP subdivision. A 30% 
transfection of the C2 neurons was also observed and there was no virus spread to 
the ventrally located A1 and C1 neurons (Figure 4.4).  This mouse also showed a 
higher number of apnoeas in the first exposure to hypoxia (Figure 4.1), but this was 
not maintained and the respiratory responses to subsequent exposures to hypoxia 
were no different from normal animals (Figure 4.1). 
Mouse 835: Injection of the Cre-recombinase viral vector into the dorsal brainstem 
of this mouse resulted in the transfection of the rostral C3 adrenergic neurons located 
in the midline of the brainstem after 3.5 weeks. There was no transfection of other 
catecholaminergic neuronal groups in the brainstem (Figure 4.5). 
Mouse 840: Transfection of the catecholaminergic neurons in the ventral portion of 
the brainstem of the above mouse was observed when the ventral region of its 
brainstem was injected with the Cre- recombinase viral vector. After a period of 3.5 
weeks, 95% transfection was observed in the A1 neuronal population, while 79% 
transfection was seen in the C1 adrenergic neurons. There was no virus spread to the 
A2 and C2 cell groups (Figure 4.6). This mouse also showed a higher number of 
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apnoeas in the first exposure to hypoxia (Figure 4.1), but as with mouse 834 this was 
not maintained and the respiratory responses to subsequent exposures to hypoxia 
were no different from normal animals (Figure 4.1). 
Mouse 842:  Injection of the Cre-recombinase viral vector into the ventral portion of 
the brainstem of mouse 842 resulted in the transfection of the ventrally located A1 
and C1 neuron groups after 3.5 weeks, with no transfection of other 





Injection of an AAV viral vector carrying the Cre-recombinase sequence into the 
brainstem of AMPK DFlox mice, to induce AMPK knockout in virally infected 
neurons, resulted in varying levels of viral infection in different brainstem areas in 
the six animals used in this pilot study.  Unfortunately this did not result in a 
corresponding respiratory phenotype as that observed in the AMPK DKO mice, in 
any of these animals (Figure 4.1).  
Although a high number of hypoxia-induced apnoeas were observed in three animals 
during their first exposure to the hypoxia challenge (Figure 4.1, upper panel), this 
was not accompanied by a hypoventilation as seen in the DKO animals.  In addition, 
the virally infected regions of the brainstem were not consistent between these three 
animals (Figures 4.2, 4.4 and 4.6), and the hypoxia-induced apnoeas were not 
observed in the subsequent exposures of the same animals to hypoxia (Figure 4.1). 
This indicates that the apnoeas were not due to a virally-induced knockout of AMPK 
in key neurons that produce the phenotype seen in DKO animals, but instead they 
were probably due to some mechanical damage or trauma to the brainstem of these 
animals, which gradually healed over the period of 2-3 weeks after surgery.  
The lack of a DKO-like respiratory phenotype in any of the virally-injected animals 
could be due to the titre of virus injected not being high enough for adequate 
transfection of the targeted brainstem regions, thereby limiting the deletion of 
AMPK in these neuronal populations.  It is of interest to note that there was a poor or 
no viral transfection of the A2 neurons in the SubP region of the NTS, in the mice 
that had dorsally-targeted injections (mice 834, 35%; 836, 0%; 844, 43%), perhaps 
because of its highly vascularised structure in close proximity to the AP.  Thus it is 
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plausible that such low or no of transfection of the SubP neurons, which may play a 
crucial role in mediating the hypoxic hypo-ventilatory response as discussed in 
Chapter 2, might explain the lack of the abnormal respiratory phenotype in virally- 
injected animals.  
On the other hand, it is interesting to note that in a number of animals receiving 
ventrally-targeted virus injections, there was a high percentage of virally infected 
cells in the ventral A1 and C1 regions (e.g. mouse 840). Nevertheless, these animals 
did not show any abnormal hypoxia-induced respiratory phenotype. This indicates 
that the knockout of AMPK in these ventral regions is not sufficient to induce the 
hypoxia-induced apnoeas and hypoventilation observed in DKO animals. This is 
additional suggestive evidence that AMPK plays an important role in the dorsal 
brainstem neurons, in particular the SubP neurons in the NTS, as opposed to the 
ventral brainstem regions, in generating the hypoxia-induced apnoeas and 
hypoventilation in DKO animals (Chapter 2). 
Also, it is reasonable to argue that the absence of a similar respiratory phenotype in 
the virally – injected mice as compared to the conditional AMPK knock out animals 
could be due to some compensatory changes / responses that have occurred during 
the development and growth of the conditional DKO mice. The ability of AMPK in 
coupling the energy status of the cell to its metabolic processes is achieved through 
the acute modulation of major metabolic enzymes (direct phosphorylation) and via 
slower transcriptional changes within the cell, thus AMPK controls the expression of 
quite a number of genes especially those involved in mitochondrial biogenesis, 
energy production and oxidative stress response (Canto and Auwerx, 2010). 
Therefore it is expected that lack of AMPK  from the onset of the mice development 
(as in the conditional AMPK DKO mice) may results in compensatory genetic 
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modulation of the downstream targets of AMPK leading to the expression of the 
respiratory phenotype in these mice as opposed to the virally –induced AMPK 
knock-out mice. Other compensatory responses may include changes in cell-cell 
communication between the AMPK deficient catecholaminergic neurons within the 
SubP and other regions of NTS with the non- catecholaminergic neurons in these 
areas resulting in the observed phenotype.  Furthermore the lack of a corresponding 
phenotype in the virally –induced AMPK knock-out mice in comparison to the 
conditional DKO upon exposure to hypoxia may be due to the fact that a 
simultaneous deletion of AMPK in all the catecholaminergic neuronal cells and that 
of the carotid body is required for the  full expression of this phenotype.  
Intriguingly this pilot study if extended will open research doors for further 
elucidation of the specific brainstem neuronal groups (and their roles) in the central 
control of oxygen sensing as well as their interaction with the peripheral carotid 
body.  For example, the relationship between the peripheral carotid body and these 
central (brainstem) oxygen sensors during hypoxia could be investigated via the use 
an in situ dual perfused animal preparation which allows for separate perfusion (with 
varying PO2 ) of the central and peripheral oxygen sensing components of the body 
(Day and Wilson, 2007; Dutia, 2012 {lab preparation}). Also the specific group(s) or 
sets of brainstem neurons (including those of the SubP) that are involved in oxygen 
sensing during hypoxia could be ascertained by using optogenetics procedure which 
involves the use of light to manipulate the neural activity of these functionally 
defined cells (Packer et al., 2013). Other techniques that could be utilised to further 
investigate specific key oxygen sensing neuronal populations within the central loci 
(brainstem) include electrophysiological methods and double/triple 
immunohistochemical procedures that target specific protein(s) that are expressed 
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only by an identified group of neurons in a region ( e.g the SubP subregion of the 
NTS). 
Overall the results of this pilot study are encouraging and with more precise 
targeting of brainstem areas, using higher virus titres, fewer injection sites per animal 
and a simultaneous deletion of all the catecholaminergic cells in the brainstem and 
that of the carotid body, it is possible that better replication of the DKO phenotype 
could be obtained. However the high vascularisation of the AP and the neighbouring 
SubP region of the NTS, may make it difficult to deliver sufficient viral titres to 
achieve a 100% infection of SubP neurons but this challenge may be circumvented 
by the utilisation of some of the earlier mentioned techniques to further investigate 
and established the oxygen sensing function of the SubP neurons as well as that of 
the other identified brainstem regions. Interestingly further studies are presently 
underway to extend these pilot observations and the results from such studies will 
throw more light on the role of the SubP neurons as well as other brainstem 
catecholaminrgic cells in oxygen sensing.  
  
    
Figure 4.1 : Respiratory responses to hypoxia in virus-injected mice.  The 
breathing rate (breaths/minute), left column, and the number of 
apnoeas/minute (right column) are shown for each animal in the pilot study. 
A, Run1 two weeks after virus injection. B, Run 2, 3 weeks post-injection and 
C, 3.5 weeks post-injection. Note the high incidence of apnoeas in three of 




Mouse 844 TH+ve cells per 100 um2 
Total Virus(-) Virus(+) 
 
 
N N N % Transfection 
A2 
SubP 10.6 6.1 4.6 43 
Medial 10.0 3 7.0 70 
SolC 9.3 3.7 5.7 61 
Ventral 7.1 1.6 5.4 76 
Ventrolateral 5.5 0.8 4.7 85 
A1 3.2 2.9 0.3 9 
C1 4.4 0.2 4.2 95 
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Figure 4.2 : Immunohistochemistry of  Cre- virus-injected transfection  of 
brainstem catecholaminergic neurons in mouse 844. (a) shows co-
localization of cre-virus (green)/ TH+ve  neuron(red) in the different 
subdivisions of the NTS region,  (b) the A1 region, (c) the C2 region and (d)  
the C1 region. (e) table, showing  % transfection  of each of these  
brainstem areas . Scale bars in (a), (b), (d) 20 μm, 40μm in (c). 
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Mouse 836 TH+ve cells per 100 um2 
Total Virus(-) Virus(+) 




SubP 20.2 20.2 0 0 
Medial 14.8 14.2 0.5 4 
SolC 19.4 15.8 3.7 19 
Ventral 20.6 13.7 6.9 33 
Ventrolateral 18.3 12.5 5.8 32 
A1 7.1 3.1 4 56 
C1 - - - - 















Figure 4.3 : Immunohistochemistry of  Cre- virus transfection  of brainstem 
catecholaminergic neurons in mouse 836. (a) shows co-localization of cre-virus 
(green)/ TH+ve  neuron(red)  mostly in the ventrolateral  subdivision of the NTS 
region, (b) the C2 region, (c) the A1 region.  (d)  table, showing  % transfection  of 






Mouse 834 TH+ve cells per 100 um2 
Total Virus(-) Virus(++) 
N N N %Transfecoion 
A2 
SubP 6.8 4.4 2.4 35 
Medial 7.9 0.5 7.4 94 
SolC 7.6 0.3 7.3 96 
Ventral 9.4 0.3 9.1 97 
Ventrolateral 8.9 0.3 8.4 96 
A1 - - - - 
C1 - - - - 













Figure 4.4 : Immunohistochemistry of  Cre- virus-injected transfection  of 
brainstem catecholaminergic neurons in mouse 834. (a) shows co-
localization of Cre-virus (green)/ TH+ve  neuron(red) in different 
subdivisions of the NTS, (b) the C2 region,  and (c) table, showing  % 




Mouse 835 TH+ve cells per 100 um2 
Total Virus(-) Virus(+) 




SubP - - - - 
Medial - - - - 
SolC - - - - 
Ventral - - - - 
Ventrolateral - - - - 
A1 - - - - 
C1 - - - - 
C2 - - - - 





Figure 4.5 : Immunohistochemistry of  Cre- virus-injected transfection  of  
C3 catecholaminergic neurons in mouse 835 (a).  (b)  table, showing  % 
transfection  of neurons observed in the  different  brainstem regions. 
Scale bar in (a), 20 μm .  
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Mouse 840 TH+ve cells per 100 um2 
Total Virus(-) Virus(+) 
N N N % Transfection 
A2 
SubP - - - - 
Medial - - - - 
SolC - - - - 
Ventral - - - - 
Ventrolateral - - - - 
A1 4.0 0.2 3.8 95 
C1 4.9 1 3.8 79 




Figure 4.6 : Immunohistochemistry of  Cre- virus-injected transfection  of 
brainstem catecholaminergic neurons in mouse 840. (a)  and (b) show the 
A1 and C1 regions respectively.  (c) table, showing  % transfection of TH+ve 
cells by cre-virus in the different regions of the brainstem. Scale bars in (a) 




Mouse 842 TH+ve cells per 100 um2 
Total Virus(-) Virus(+) 
N N N % Transfection 
A2 
SubP - - - - 
Medial - - - - 
SolC - - - - 
Ventral - - - - 
Ventrolateral - - - - 
A1 4.1 0.6 3.5 85 
C1 4.7 0 4.6 100 






Figure 4.7 : Immunohistochemistry of  Cre-virus-injected transfection  of 
brainstem catecholaminergic neurons in mouse 840. (a)  and (b) show the 
A1 and C1 regions respectively,  (c) table, showing  % transfection  of 
TH+ve cells by Cre-virus in the different brainstem regions of interest. Scale 







The work in this thesis has shown that conditional deletion of the α1 and α2 
isoforms of the α-catalytic subunit of AMPK in catecholaminergic (TH+ve) cells in 
mice resulted in marked abnormalities in their ventilatory response to hypoxia. 
The observed abnormalities included hypoventilation in association with 
prolonged and frequent apnoeas, confirming the earlier findings of Mahmoud et 
al. (2015a, b).  
Investigation into the possible physiological basis of the above respiratory 
abnormalities revealed that, in spite of the fact that the response of the carotid 
body afferents to hypoxia in these mice is normal (Mahmoud et al 2015b), there 
was a significant decrease in the activation of specific catecholaminegic neuronal 
populations in the dorsal brainstem that are known to be involved in the control of 
breathing (Results, Chapter 2). Prominent reductions in activation, indicated by c-
Fos expression, were seen in the A2 noradrenergic neurons in the SubP region of 
the nucleus tractus solitarius (NTS), and in the C2 adrenergic neurons of the dorsal 
brainstem. This finding implies that AMPK in these catecholaminergic neurons has 
an important role in regulating their responsiveness to the afferent excitatory 
inputs they receive from the carotid sinus nerve, so that in the absence of AMPK 
these neurons fail to respond adequately to the otherwise normal carotid nerve 
afferent firing.   
112 
 
The NTS is a critical integrating centre which mediates chemosensory afferent 
information from the peripheral carotid bodies to the ventral brainstem areas that 
are involved in the regulation of breathing. Catecholaminergic neurons in the 
brainstem play a fundamentally important role in the control of respiration, as 
evidenced by the profound and ultimately fatal respiratory arrhythmias and 
breath-holding that result from the loss of these neurons in, for example, Rett 
syndrome (Viemari et al., 2006; Stettner et al., 2007; Smith et al., 2013). The 
hypoventilation and apnoeas observed in AMPK-null mice may therefore be 
causally linked to the reduced response and decreased activation of the dorsal 
brainstem catecholaminergic neurons during hypoxia. Thus, while in Rett 
syndrome the irreversible loss of the catecholaminergic neurons causes 
profoundly disordered breathing, the reduced activation of the catecholaminergic 
neurons in AMPK-null mice may cause the less profound signs of hypoventilation 
and prolonged apnoeas during hypoxia, as first observed by Mahmoud (2015a) 
and also in this work. 
Indeed the present work identifies for first time that the A2 catecholaminergic 
neurons in the SubP region of the NTS, in particular, may be crucial in mediating 
the hypoxia-induced hyperventilatory response in normal animals. Of all the 
brainstem catecholaminergic neuronal groups, the most marked reduction in 
activation was observed in this region, along with a lesser effect in C2 region, in 
AMPK-null mice after exposure to hypoxia. By contrast, catecholaminergic neurons 
in the other regions of the dorsal brainstem showed either no change or an 
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increase in activation (Figure 2.11).  As discussed in Chapter 2, the SubP neurons 
lie in close proximity to the highly vascularised area postrema (AP), and share an 
intimate specialised blood supply with it (Fodor et al., 2007; McGinnis et al., 2013), 
putting them in a very suitable position to respond to changes in systemic pO2.  
The present results, which show that a markedly reduced activation of the SubP 
neurons is associated with the hypoxic hypoventilation and prolonged apnoeas in 
AMPK-null mice, indicate that the deletion of AMPK in these neurons reduces or 
prevents their normal activation by hypoxia. As suggested in Figure 2.12, the 
normal hypoxia-induced hyperventilatory response therefore appears to require 
both the normal carotid body afferent excitatory input to the NTS neurons, and 
simultaneously a local, AMPK-dependent response to the hypoxic stimulus. In 
AMPK-null mice the failure of the local hypoxic response after AMPK deletion, 
results in a reduced activation of these cells and may thus explain the respiratory 
abnormalities observed in these animals.  
The convergence of the carotid body afferent inputs and the local hypoxic AMPK-
dependent response may occur in the same neuronal population (likely SubP 
neurons), or alternatively this may involve efferent projections from the SubP 
neurons to other regions of the NTS which receive the excitatory inputs from the 
carotid body afferents. Presently little is known of the micro-circuitry of the SubP 
and the other sub-regions of the NTS, and the corresponding areas of termination 
of the carotid body afferent axons.    
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 Interestingly the result from this work synchronises and aligns well with earlier 
reports from functional magnetic resonance imaging studies (fMRI) in the brain of 
anesthetised AMPK mutant mice during hypoxia (Mahmoud et al., 2015b). From 
their work they showed that upon exposure to hypoxia (8% O2) AMPK DKO mice 
brains in contrast to the control DFlox mice displayed reduction in O2- 
consumption (as indicated by a decrease in the BOLD signal) in two –well defined 
dorsal (DAR) and ventral (VAR) active regions of the brainstem (see Figure 5.1; 
Mahmoud et al., 2015b). The dorsal region was shown to be consistent with the 
caudal subdivisions of the NTS containing A2 noradrenergic neurons as well as the 
C2 region which comprises adrenergic neurons (areas which showed reduction in 
c-fos expression in this work) both of which receive sensory inputs from the 
carotid body while the ventral active area equally  aligns well with the A1/C1 
catecholaminergic cells of the ventral medulla (notice in Figure 2.10 ; the decrease 
in c-fos expression in A1 cells in this work) that receives afferent chemosensory 
information from the carotid body relayed via the NTS (Figure 5.1; Mahmoud et 
al., 2015b). Therefore the result from this work corroborating with this earlier 
study allows for a proper identification of the specific areas or loci of the 
brainstem chemosensory circuit that might have been interrupted during hypoxia 
by the deletion of AMPK resulting in the respiratory phenotype that was seen in 
these mice. Furthermore it enhances the understanding of the role of AMPK in 
mediating the oxygen sensing function of these identified catecholaminegic 
brainstem neurons during the period of hypoxic stress.  
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 In the light of the above, Mahmoud et al. (2015b) have argued that the 
hypoventilatory response observed in AMPK DKO mice during hypoxia may be due 
to failure in central integration and transduction of chemosensory inputs from the 
carotid body as a results of the inability of these brainstem catecholaminergic 
neurons to respond appropriately to metabolic stresses because of the lack of 
AMPK.  A postulated new mechanism of the integration by AMPK at the level of 
the brainstem of the local and metabolic stresses during hypoxia is as shown in 
Figure 5.2 (Mahmoud et al., 2015b). 
   The identification of the SubP and to a lesser extent the C2 regions of the dorsal 
brainstem as key areas in which a local, AMPK-dependent response to hypoxia is 
required for normal breathing, is likely to be important in understanding the 
mechanisms underlying some breathing disorders in humans. In particular, 
breathing disorders during sleep (sleep apnoeas) are a significant health concern. 
While the majority of sleep apnoeas are believed to be obstructive (due to the 
muscles and soft tissues in the throat collapsing sufficiently during sleep to cause a 
blockage of the airway), some sleep apnoeas have also a central origin, in a 
reduced or interrupted drive to breathe (central sleep apneas, or mixed complex 
apneas). Central sleep apnoeas constitute about 11% of the total apnoeas (both 
obstructive and non-obstructive) that are experienced by the adult population, 
while in children and infants its prevalence rises to about 40 - 90% (Nakamura and 
Kuwaki, 2003). Presently the mechanisms involved in central sleep apnoeas are 
largely unknown. The present results, which for the first time demonstrate that an 
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AMPK-dependent hypoxic response of dorsal NTS (SubP and C2) neurons is 
necessary for the normal respiratory modulation, suggest a potential brainstem 
mechanism that may be involved in central sleep apnoeas. Thus, disorders in 
AMPK regulation or function in dorsal NTS catecholaminergic neurons may 
precipitate apnoeas and hypoventilation in patients with mild obstructive 
apnoeas, where partial blockage of the airway and consequent hypoxia induces 
the abnormal respiratory phenotype observed in AMPK-null animals in this work. 
The localisation of the SubP and C2 regions of the NTS as potentially key regions 
where central sleep apnoeas could arise, offers new avenues for investigation of 
the underlying mechanisms, and also in the longer term the potential for targeted 
diagnostic and therapeutic interventions based on an understanding of the role of 
AMPK in mediating the response to hypoxia in these neurons.   
Interestingly, comparison of the activation of SubP A2 neurons in AMPK-null 
animals with that in AMPK α2-null animals, showed that the marked reduction in 
activation was observed only in after the deletion of both α1 and α2 isoforms, 
while the activation of these neurons in AMPK α2-null animals was normal (Figure 
2.11). This suggests that the AMPK α1 isoform has a particularly important role in 
SubP neurons, while loss of the AMPK α2 isoform has no effect. This could be 
explained for example by the selective expression of only the α1 isoform in the 
SubP neurons, so that deletion of the AMPK α2 isoform in the AMPK α2-null 
animals does not have any effect on these cells. By contrast, in the other regions 
of the NTS deletion of the AMPK α2 isoform in the AMPK α2-null  animals results 
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in a significant hyperplasia of the catecholaminergic neurons compared to both 
the normal and AMPK-null animals (Figure 2.10). There is no hyperplasia in the 
SubP region when the AMPK α2-null mice are compared to the AMPK DKO, again 
suggesting that the AMPK α2 isoform may not be expressed in these neurons. At 
present there is no information about the relative expressions of the different α1 
and α2 isoforms in these regions of the brainstem. In order to fully understand the 
role played by AMPK in mediating the local hypoxic response in these neurons, it 
will be important to clarify the expression profile of each of these isoforms in the 
different brainstem areas.  
The hyperplasia of catecholaminergic neurons in the AMPK α2-null animals is in 
line with the known function of AMPK in inhibiting cell proliferation, both in non- 
malignant and tumor cells (e.g hepatoma). Currently AMPK is postulated to be a 
plausible therapeutic target for proliferative disorders such as atherosclerosis and 
cancers such as glioblastoma, melanoma and advanced prostate cancer 
(Motoshima, et al., 2006), because of its role in regulating cell proliferation. In the 
present work, marked hyperplasia was observed in the dorsal brainstem NTS 
neurons as well as those of the ventral A1 region (but not in the other 
catecholaminergic cell groups), specifically after deletion of the AMPK α2 isoform 
(Figure 2.10). Indeed the hyperplasia in AMPK α2-null animals was greater than in 
AMPK-null (DKO) animals. This is an interesting finding as it suggests that the 
selective deletion of the AMPK α2 isoform, presumably leaving intact the selective 
expression of only the AMPK α1 isoform, appears to simulate the hyperplasia in 
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the dorsal NTS neurons. Thus the cell proliferation stimulated by AMPK appears to 
involve the AMPK α1 isoform, while the AMPK α2 isoform, when it is present, 
appears to inhibit cell proliferation and prevents hyperplasia. In addition, it is not 
clear why the hyperplasia is observed in the noradrenergic cell groups (A1and A2, 
but not in adrenergic cell groups (C1 and C2) (Figure 2.10). As noted above the 
expression profile of these isoforms in the brainstem neurons is presently not 
known, so the interpretation of the present findings remains speculative. 
Understanding the possible different roles of the two AMPK isoforms however, 
may be an important step in determining how they regulate cell proliferation in 
central neurons.  
In an attempt to develop a methodology to further investigate the role of AMPK 
and its selective targeted deletion in specific areas of the brainstem, the pilot 
study was carried out in the work to use a virus vector injected into the target 
areas to produce the localised deletion of AMPK in these areas (Chapter 4). In 
these initial experiments, a number of injections of virus were made into either 
the dorsal, ventral or both dorsal and ventral areas of the brainstem, in order to 
produce a widespread deletion of AMPK and determine if the respiratory 
phenotype of prolonged apnoeas and hypoventilation could be produced, similar 
to that seen in the AMPK-null animals. In the event it proved difficult to achieve 
consistently high transfection rates of the catecholaminergic neurons in the 
targeted areas, and the respiratory phenotype of the AMPK-null mice was not 
observed in any of the injected animals. Given the suggested crucial importance of 
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the dorsal brainstem SubP and C2 neurons in mediating the normal ventilatory 
response to hypoxia, as discussed above, it was of particular interest to achieve a 
high transfection rate and AMPK deletion in these specific areas. However, 
perhaps because of the high vascularity of the AP region in close proximity to the 
SubP neurons, this was not achieved in any of the animals, even those that 
received virus injections targeted towards the dorsal brainstem. This could explain 
why the respiratory phenotype of the AMPK-null animals was not observed in any 
of the injected animals, if the knock-out of AMPK in SubP neurons is essential for 
the effects to be observed. Interestingly, in animals that received ventrally-
targeted injections, high transfection rates were achieved in the A1 and C1 ventral 
catecholaminergic neuron groups, but this did not result in the prolonged apnoeas 
and hypoxic-hypoventilation seen in AMPK-null animals (Chapter 4). This supports 
the notion that it is the deletion of AMPK in the dorsal NTS neurons, particularly in 
the SubP region, that results in the abnormal hypoxic ventilatory response, while 
AMPK deletion in the ventral catecholaminergic cell groups has no effect on the 
breathing pattern.  
In contrast to the effects of AMPK deletion observed in the central 
catecholaminergic neurons, the limited results obtained in this work in the 
peripheral carotid bodies (Chapter 3) suggest that in AMPK-null animals there is a 
reduction in the number of TH+ve catecholaminergic cells compared to normal. 
Unfortunately the number of animals from which useful data was obtained is too 
small to allow a firm conclusion to be made. Indeed it is likely that, because of the 
120 
 
dispersed nature of the carotid bodies in the mouse, the observed result may be 
explained by experimental bias in selecting the clusters of TH+ve cells that were 
counted in the histological sections. If indeed there is a loss of peripheral carotid 
body cells after AMPK deletion in AMPK-null mice, it will be interesting to identify 
the role of AMPK in these cells and contrast this with the better-known effects of 
AMPK in regulating cell proliferation, as discussed above. Thus in a range of 
tissues, including the dorsal NTS neurons as observed in this work, AMPK 
inhibition or deletion leads to the stimulation of cell proliferation, while in the 
peripheral carotid bodies there would appear to be the opposite effect. 
Furthermore, it will also be interesting to determine how the afferent discharge 
and hypoxia-evoked firing of the carotid body afferents recorded in the carotid 
sinus nerve in vitro remains normal in AMPK-null animals (Mahmoud et al 2015b), 
if there is indeed a loss of catecholaminergic cells in the carotid bodies. Thus for 
the moment the question of the effects of AMPK deletion on the 
catecholaminergic cells in the peripheral carotid bodies remains open, and awaits 
further investigation. 
Overall the findings of this work contribute to the understanding of the role of 
AMPK, a key regulator of energy metabolism in cells and tissues, in the control of 
respiration during hypoxia. The demonstration of the importance of AMPK in 
dorsal brainstem neurons in mediating the response to hypoxia, particularly in the 
A2 SubP and the C2 regions, indicates for the first time a specific central site of 
action of AMPK in central respiratory control. These findings may be of relevance 
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in further understanding the mechanisms involved in central disorders of 
breathing, as in central or mixed complex sleep apnoeas, and may offer in the 
longer term opportunities to develop therapeutic interventions in managing such 
disorders. 
 
Figure 5.1:  Functional magnetic imaging demonstrating that AMPK deletion 
inhibits activation by hypoxia of the dorsal and ventral regions of the 
brainstem. (A) Shows records of frequency (breaths/min) versus time during 
hypoxia (8% O2) for anaesthetised AMPK DFlox (black, n=6) and AMPK DKO 
(red, n=6) mice. (B)  Bar charts showing the mean±SEM for change in 
breathing frequency during hypoxia; p˂0.01. (C) Dorsal (DAR) and ventral 
(VAR) active regions of the brainstem that showed significantly lower signal 
change (p˂ 0.005) during hypoxia in DKO mice compared to DFlox controls. 
(D) Variability of signal time courses for DAR and VAR in blue for each 
individual mouse ( same mice for A lower panel) overlaid on mean signal for 
DFox mice (black) and DKO mice (red line). AU = arbitrary units. (E) 
Mean±SEM percentage signal changes for DAR and VAR during hypoxia in 
DFlox versus DKO mice (same mice as for A, lower panel).*= p˂0.05; 
**=p˂0.01 (Mahmoud et al.,2015b).
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Figure 5.2.  Figure legend on the next page  
(Mahmoud et al., 2015b)
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Figure 5.2.   A schematic diagram showing the new hypothesis on the integration by 
AMPK of local and applied metabolic stresses during hypoxia. AMPK is activated by 
increase in AM(D)P/ATP ratio as a result of local hypoxic stress within the  NTS 
(decreased ATP supply) alongside with applied metabolic stress (increased ATP usage)  
and /or increased cytoplasmic  Ca2+ (not shown) delivered through sensory input from 
the carotid bodies which is in turn relayed to the ventrolateral  A1 neurons . The sensory 
input and brainstem hypoxia could thus jointly determine the set point at which the 
AMPK and invariably the brainstem respiratory network are activated during hypoxia.  
AMPK thereafter modulates cellular metabolism, ion channels, neuronal firing 
frequency and /or neurotransmitter release with a resultant facilatatory effect on 
efferent output leading to an increased drive to breathe in a manner that could be 
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